@article {pmid41871620,
year = {2026},
author = {Silva, DJD and Silveira, SCD and Souza, LC and Cruzeiro, MM and Vale, TC},
title = {Clinical and Sociodemographic Profile of Familial Amyotrophic Lateral Sclerosis Type 8 Compared to the Sporadic Form.},
journal = {Arquivos de neuro-psiquiatria},
volume = {84},
number = {3},
pages = {1-8},
doi = {10.1055/s-0046-1817037},
pmid = {41871620},
issn = {1678-4227},
mesh = {Humans ; *Amyotrophic Lateral Sclerosis/epidemiology/diagnosis/genetics/physiopathology/classification ; Female ; Male ; Middle Aged ; Adult ; Brazil/epidemiology ; Aged ; Age of Onset ; Socioeconomic Factors ; Retrospective Studies ; Sociodemographic Factors ; },
abstract = {Amyotrophic lateral sclerosis (ALS) is a rare degenerative disease of motor neurons, predominantly sporadic, with approximately 10% of the cases showing familial inheritance.To characterize the clinical and sociodemographic profile of patients with familial ALS type 8 (fALS8) and compare it with sporadic ALS (sALS).We reviewed the medical records (1997-2022) from a specialized Brazilian center. Patients with a confirmed diagnosis of ALSs were included, and sociodemographic and clinical data were collected.The sample was composed of 89 ALS patients, with a slight female predominance (53%) and a high frequency of fALS8 cases (45%). The fALS8 patients were diagnosed at a younger age, at approximately 50 years, compared to 53 years among the sALS patients (p = 0.043). Lower limb onset predominated in the fALS8 group (87%), while the sALS group showed more heterogeneous presentations, including bulbar onset (14%). The time until the diagnosis was significantly longer in the fALS8 group compared to the sALS group, both from symptom onset (approximately 51 versus 30 months respectively; p < 0.001) and after admission to a specialized center (7 versus 4 months respectively; p = 0.002). Dysphagia and gastrostomy were more frequent in the sALS group compared to the fALS8 group (p = 0.02 and p < 0.01 respectively), and older age at diagnosis was associated with worse functional scores.The fALS8 group presented with distinct clinical and demographic features compared to the sALS group, including younger age at diagnosis, more homogeneous symptom onset, and lower frequency of dysphagia and need for gastrostomy. The diagnosis was more delayed in the fALS8 group, and older age at diagnosis was associated with worse functional status. The current study contributes to the scarce data on fALS8 in South America.},
}

Humans
*Amyotrophic Lateral Sclerosis/epidemiology/diagnosis/genetics/physiopathology/classification
Female
Male
Middle Aged
Adult
Brazil/epidemiology
Aged
Age of Onset
Socioeconomic Factors
Retrospective Studies
Sociodemographic Factors

@article {pmid41872337,
year = {2026},
author = {Croteau, E and Rousseau, E and Tremblay, S and Rousseau, JF and Espinosa-Betancourt, E and Lavallée, E and Dubreuil, S and Ait-Mohand, S and Lareau-Trudel, É and Gosselin, S and Carrier, V and Côté-Bigras, S and Allard, C and Maier, M and Salzmann, M and Tétu, A and Houde, MP and Turcotte, É and Guérin, B},
title = {A phase I study to evaluate the dosimetry and safety of [[89]Zr]Zr-DFO-AP-101, a new antibody-based radiopharmaceutical to detect misfolded SOD1 in amyotrophic lateral sclerosis.},
journal = {European journal of nuclear medicine and molecular imaging},
volume = {},
number = {},
pages = {},
pmid = {41872337},
issn = {1619-7089},
support = {Fonds d'accélération des collaborations en santé (FACS)//Ministère de la Santé et des Services sociaux/ ; },
}

@article {pmid41872984,
year = {2026},
author = {Toomey, A and Kleinerova, J and Tan, EL and Siah, WF and Bede, P},
title = {Muscle MRI and Muscle Ultrasound Applications in MND/ALS: Academic Insights and Clinical Opportunities.},
journal = {European journal of neurology},
volume = {33},
number = {3},
pages = {e70582},
doi = {10.1111/ene.70582},
pmid = {41872984},
issn = {1468-1331},
support = {HRB JPND-Cofund-2025-3/HRBI_/Health Research Board/Ireland ; JPND-2025"Qual-Bulb-MND"//EU Joint Programme - Neurodegenerative Disease Research/ ; SFI-SP20/SP/8953/SFI_/Science Foundation Ireland/Ireland ; },
mesh = {Humans ; *Amyotrophic Lateral Sclerosis/diagnostic imaging ; *Magnetic Resonance Imaging/methods ; Ultrasonography/methods ; *Muscle, Skeletal/diagnostic imaging ; },
abstract = {BACKGROUND: There is an unmet need for the clinically relevant ALS biomarkers to facilitate an accurate diagnosis in suspected cases, monitor disease progression and evaluate response to therapy in clinical trials. While the MND/ALS literature is dominated by innovative brain studies, motor disability in ALS is primarily driven by neurogenic muscle change impacting mobility, dexterity, respiratory and bulbar function.

METHODS: With the intention of raising awareness of muscle-derived imaging markers in ALS, a systematic review has been conducted. Study designs, imaging methods, data interpretation frameworks, and cohort characteristics were systematically evaluated to identify innovative approaches and barriers to clinical implementation.

RESULTS: A total of 219 studies were screened and 73 original studies selected for systematic review; 37 muscle MRI studies and 36 studies using ultrasound, PET or CT. All of the selected studies successfully captured ALS-associated muscle degeneration and their methods included the evaluation of muscle dimensions (thickness/volumes n = 34), 'acute' denervation (water content, n = 15), fasciculation counts (n = 14), 'chronic' neurogenic change (fat content, n = 21), metabolic changes (n = 4), diffusion alterations (n = 8) and echo intensity changes (n = 13).

CONCLUSIONS: Despite the huge impact of lower motor neuron dysfunction on the patients' independence, survival and quality of life, muscle imaging is a glaringly overlooked frontier of MND/ALS research. This is a missed opportunity, as a variety of non-invasive quantitative muscle imaging techniques have been successfully used in other neurological conditions; these protocols are easy to implement on commercial MRI and ultrasound platforms and recent studies have demonstrated their ease of use and potential clinical utility.},
}

Humans
*Amyotrophic Lateral Sclerosis/diagnostic imaging
*Magnetic Resonance Imaging/methods
Ultrasonography/methods
*Muscle, Skeletal/diagnostic imaging

@article {pmid41873182,
year = {2026},
author = {Hinten, AE and Imuta, K},
title = {Executive Function Costs of Fantastical Interference in Narrative Comprehension: A Response to Lillard's (2026) Commentary.},
journal = {Developmental science},
volume = {29},
number = {3},
pages = {e70177},
doi = {10.1111/desc.70177},
pmid = {41873182},
issn = {1467-7687},
mesh = {Humans ; *Comprehension/physiology ; *Executive Function/physiology ; Child ; *Fantasy ; *Narration ; Child, Preschool ; Cognition ; },
abstract = {Through bringing together previous findings from 16 studies involving 121 effect sizes (based on 1,297 1.5- to 6-year-olds), Hinten et al.'s (2025) meta-analysis revealed that children who viewed fantastical media in an experimental setting performed worse on inhibitory control and cognitive flexibility tasks immediately post-viewing compared to those exposed to realistic media. Lillard's (2026) commentary provided one potential explanation for our findings, revolving around the idea that processing fantastical content is cognitively taxing because it conflicts with existing schemas. In this response, we extend Lillard's (2026) perspective by drawing on Loschky et al.'s (2020) Scene Perception and Event Comprehension Theory (SPECT) to provide an additional explanation: Fantasy overloads children's executive functions because it interferes with their narrative comprehension. SUMMARY: We present a novel perspective on why fantastical media may have adverse, short-term effects on children's executive functioning. Children's executive functions may become overloaded while watching fantastical media because fantastical elements can detract from and hamper narrative comprehension processes.},
}

Humans
*Comprehension/physiology
*Executive Function/physiology
Child
*Fantasy
*Narration
Child, Preschool
Cognition

@article {pmid41874673,
year = {2026},
author = {Li, J and Gao, C and Wang, Q and Liu, J and Xie, Z and Zhao, Y and Yu, M and Zheng, Y and Lv, H and Zhang, W and Yuan, Y and Meng, L and Deng, J and Wang, Z},
title = {Aberrant SOD1 aggregates in skeletal muscle target fibers in amyotrophic lateral sclerosis.},
journal = {Acta neuropathologica},
volume = {151},
number = {1},
pages = {},
pmid = {41874673},
issn = {1432-0533},
}

@article {pmid41875078,
year = {2026},
author = {Mamede, LD and Hu, M and Vaquer-Alicea, J and Titus, AR and Passos, PM and Lantelme, E and French, RL and Kirschner, PA and Diamond, MI and Miller, TM and Ayala, YM},
title = {A quantitative cell-based reporter links TDP-43 aggregation and dysfunction to define pathogenic mechanisms.},
journal = {PLoS biology},
volume = {24},
number = {3},
pages = {e3003662},
doi = {10.1371/journal.pbio.3003662},
pmid = {41875078},
issn = {1545-7885},
mesh = {Humans ; *DNA-Binding Proteins/metabolism/genetics ; *Protein Aggregation, Pathological/metabolism/genetics ; Neurons/metabolism/pathology ; Exons ; Protein Aggregates ; RNA Splicing ; Amyotrophic Lateral Sclerosis/metabolism ; TDP-43 Proteinopathies/metabolism/genetics ; Genes, Reporter ; },
abstract = {TDP-43 pathology is a hallmark of fatal neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and limbic-predominant age-related TDP-43-encephalopathy (LATE). In affected patients, cytoplasmic TDP-43 aggregates are accompanied by disruption of its normal nuclear localization and function. Because TDP-43 is an RNA binding protein that controls transcript processing, including repression of cryptic exon splicing, its loss leads to dysregulation of gene expression. Despite its central significance in disease, the connection between TDP-43 aggregation and dysfunction remains poorly understood, and models to study the underlying mechanisms are limited. Here, we characterize a robust and quantitative cell-based reporter that captures both aggregation and the resulting loss of function. Using this human biosensor cell line, we show that aggregation initiated by prion-like seeding drives progressive depletion of nuclear TDP-43 and induces signature features of diminished TDP-43 activity, such as increased DNA damage and activation of cryptic exon splicing. We find that aggregate seeding also induces cryptic exon splicing in human neurons implying that this pathological link extends to disease-relevant models. The seeding model provides a platform for dissecting mechanisms that underlie TDP-43 pathology and for identifying factors that modulate the aggregation-to-dysfunction transition. Our data shows that aggregate seeding impacts TDP-43 autoregulation, initiating a toxic feed-forward mechanism that disrupts TDP-43 homeostasis. Furthermore, reducing ataxin-2 levels decreases aggregation and restores TDP-43 activity. Together, these findings reveal a molecularly guided strategy to directly impact TDP-43 activity by decreasing its misfolding and aggregation, highlighting approaches to prevent TDP-43 dysfunction and mitigate toxicity under pathological conditions.},
}

Humans
*DNA-Binding Proteins/metabolism/genetics
*Protein Aggregation, Pathological/metabolism/genetics
Neurons/metabolism/pathology
Exons
Protein Aggregates
RNA Splicing
Amyotrophic Lateral Sclerosis/metabolism
TDP-43 Proteinopathies/metabolism/genetics
Genes, Reporter

@article {pmid41875115,
year = {2026},
author = {Uversky, VN},
title = {Why is it so difficult to discover drugs for amyotrophic lateral sclerosis? A protein intrinsic disorder perspective.},
journal = {Expert opinion on drug discovery},
volume = {},
number = {},
pages = {1-21},
doi = {10.1080/17460441.2026.2648612},
pmid = {41875115},
issn = {1746-045X},
abstract = {INTRODUCTION: Amyotrophic Lateral Sclerosis (ALS) is the most common adult motor neuron disease, now viewed as a spectrum disorder rather than a single entity. Because of the significant person-to-person variability in the disease's biology, driven by both genetic and environmental interactions, finding a single "magic bullet" drug is unlikely. Despite decades of research, only a few ALS drugs have being developed. Drug discovery has a 95% failure rate due to genetic complexity, lack of sensitive biomarkers, diagnostic delays, inadequate animal models, and poor clinical trial design.

AREAS COVERED: This article considers several aspects related to the prevalence of intrinsic disorder in ALS-related proteins and highlights how these features might hinder rational structure-based drug discovery.

EXPERT OPINION: There is a common oversight in current drug discovery methodologies, which is the neglect of intrinsically disordered proteins (IDPs) playing several crucial roles in the pathology of neurodegeneration in general and ALS in particular. Therefore, it seems that the 'one-size-fits-all' approach to ALS is hitting a wall because these 'shapeshifters' of the cellular world are ignored. Consequently, to be more successful in finding drugs treating ALS, gears should be shifted from rational structure-based models to intrinsic disorder-centric approaches.},
}

@article {pmid41866066,
year = {2026},
author = {Qian, J and Li, C and Wang, Y and Tong, J},
title = {Extracorporeal sliding knot technique for simplified hysteroscopic suture fixation of levonorgestrel-releasing intrauterine device.},
journal = {Journal of minimally invasive gynecology},
volume = {},
number = {},
pages = {},
doi = {10.1016/j.jmig.2026.03.020},
pmid = {41866066},
issn = {1553-4669},
abstract = {OBJECTIVE: Approximately 20% of adenomyosis cases occur in women under 40 years of age [1]. While LNG-IUD is the first-line medical therapy, its treatment failure is closely associated with uterine volume [2], with expulsion rates reported as high as 37.5% in uteri exceeding 12 gestational weeks [3]. Tong et al's hysteroscopic suture fixation technique (HCSS) reduced expulsion to 2.6% [4][5]. Although clinical studies have confirmed the safety and efficacy of this technique [5], its technical complexity and the requirement for repeated instrument exchanges have limited widespread adoption. We therefore developed an optimized extracorporeal sliding knot method to overcome these barriers.

SETTING: University hospital.

PARTICIPANTS: A 45-year-old woman diagnosed with adenomyosis and prior LNG-IUD expulsion.

INTERVENTIONS: The key modification involves three critical steps: Step 1) Construction of a secure multi-loop sliding knot using 2-0 Ethibond suture attached to the "T junction" of the LNG-IUD; Step 2) Introduction of the pre-formed knot into the uterine cavity in a single maneuver using a knot-pusher; Step 3) Adjustment of the knot position under the hysteroscopic cold-knife surgery system (HCSS), achieving secure device fixation. The complete procedure obviates repeated instrument exchanges and intracavitary knot manipulation required by the original technique.

CONCLUSION: The extracorporeal sliding knot optimization preserves therapeutic efficacy while simplifying intrauterine manipulation, significantly enhancing surgical reproducibility and accessibility for widespread clinical adoption.},
}

@article {pmid41866414,
year = {2026},
author = {Li, X and Ding, W and Xu, E},
title = {Uncoupling of apnea-hypopnea index and oxygen desaturation in als: characterization and diagnostic implications of an "AHI-SpO2 dissociation" phenotype.},
journal = {Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology},
volume = {47},
number = {4},
pages = {},
pmid = {41866414},
issn = {1590-3478},
support = {202610452//Health Commission of Jiangxi Province/ ; },
}

@article {pmid41866449,
year = {2026},
author = {Wang, Z and He, F and Li, L and Wang, W and Zhang, L and Tang, J and Le, W},
title = {Sleep Disorders in Neurodegenerative Diseases: Pathological Correlations and Underlying Mechanisms.},
journal = {Neuroscience bulletin},
volume = {},
number = {},
pages = {},
pmid = {41866449},
issn = {1995-8218},
abstract = {Neurodegenerative diseases (NDDs), including Alzheimer's disease (AD), Parkinson's disease (PD), multiple system atrophy (MSA), amyotrophic lateral sclerosis (ALS), and others, represent an escalating public health burden in aging populations. NDDs are characterized by progressive neuronal loss and misfolded protein aggregation. Despite distinct clinical heterogeneity, these diseases universally present with debilitating non-motor symptoms, among which sleep-wake disorders are highly prevalent. Once considered secondary to neuronal damage, growing evidence now highlights a bidirectional interplay: sleep disruption is not only a consequence of neurodegeneration but also exacerbates its progression. This review synthesizes this complex interplay, outlining sleep phenotypes across major NDDs, dissecting key underlying mechanisms (impaired protein homeostasis, glymphatic dysfunction, chronic neuroinflammation, sleep-regulatory nucleus vulnerability, and circadian dysregulation), and summarizing current pharmacotherapeutic and non-pharmacological interventions. Attenuating sleep disorders may therefore provide symptomatic relief and disease‑modifying effects for NDDs.},
}

@article {pmid41866924,
year = {2026},
author = {Seyam, M and Morelli, KH and Waheed, W and van den Berg, LH and Tandan, R},
title = {Predicting Disease Progression and Survival in Amyotrophic Lateral Sclerosis.},
journal = {Muscle & nerve},
volume = {},
number = {},
pages = {},
doi = {10.1002/mus.70198},
pmid = {41866924},
issn = {1097-4598},
abstract = {Amyotrophic lateral sclerosis (ALS) progresses relentlessly and is characterized by a median survival of 2-5 years from symptom onset with death from respiratory failure. ALS is a complex, multi-system neurodegenerative disorder with significant phenotypic heterogeneity and markedly variable disease progression. This variability presents challenges in determining the optimal timing for therapeutic interventions, complicates clinical trial design due to lack of effective stratification methods, and makes it difficult to reliably measure the longitudinal impact of specific interventions. Accurately capturing disease progression in ALS can be challenging. We propose that early respiratory phenotyping offers a promising approach to facilitate patient stratification, improve assessments of disease progression, and predict survival.},
}

@article {pmid41867322,
year = {2026},
author = {Alabdali, A and Alharkan, M},
title = {Comparative Cost Analysis of Ambulance Utilization: Advanced Life Support (ALS) vs Basic Life Support (BLS) at King Abdulaziz Medical City, Riyadh.},
journal = {ClinicoEconomics and outcomes research : CEOR},
volume = {18},
number = {},
pages = {570790},
pmid = {41867322},
issn = {1178-6981},
abstract = {PURPOSE: Unit-hour utilization (UHU) is the most common metric for evaluating the productivity of ambulances and crews for ambulance services. Calculating UHU is essential for maximizing profitability and evaluating the number of hours of ambulance utilization during a shift. This has not been examined previously at King Abdulaziz Medical City (KAMC). KAMC is a major tertiary-care medical center in Riyadh, Saudi Arabia, with dedicated ALS (Advanced Life Support) and BLS (Basic Life Support) ambulance units. This study aimed to determine the cost of operating the emergency calls (advanced life support [ALS]) unit and non-emergency calls (basic life support [BLS]) unit and compare the costs of emergency calls (ALS) and non-emergency calls (BLS). The study used a standardized institutional checklist that itemizes expenditures across logistics, equipment, maintenance, salary, pharmacy, and fuel cost components.

METHODS: This was a retrospective cross-sectional study. Institutional Review Board approval was obtained from King Abdullah International Medical Research Center. The study examined emergency and non-emergency calls for a period of 12 months. This study was based on a checklist assessing various expenditures to calculate the cost of ambulance utilization at KAMC in 2022.

RESULTS: The total average ambulance utilization cost per year for ALS was 4,806,245.7 SR, and the average ambulance utilization cost per hour was 548.65 SR; these costs were to operate the ALS crew for 24 hours, seven days a week. Conversely, the total average ambulance utilization cost per year for BLS was 3,934,156.92 SR, and the average ambulance utilization cost per hour was 449.10 SR. The main expenses concerned salaries and overhead costs for ALS and BLS.

CONCLUSION: This study provides insights into the cost of ambulance utilization between ALS and BLS. The higher cost of ALS calls may be attributed to the higher level of training, equipment, and staffing required.},
}

@article {pmid41868461,
year = {2026},
author = {Yu, J},
title = {Postoperative acute ultra-early fish mouthing of a Surpass Evolve flow diverter leading to ischemic complication.},
journal = {Radiology case reports},
volume = {21},
number = {6},
pages = {2346-2354},
pmid = {41868461},
issn = {1930-0433},
abstract = {Currently, the Surpass Evolve flow diverter (SE FD) is widely adopted for endovascular treatment of intracranial aneurysms. Although generally safe, acute ultra-early fish mouthing remains an exceptionally rare complication. Following Torche et al.'s 2023 report of the first case, the present case represents the second documented instance. A 66-year-old woman was diagnosed with a left posterior communicating artery aneurysm and a left ophthalmic artery aneurysm. Physical examination revealed no abnormalities. The endovascular treatment (EVT) procedure was performed. After advancing a microcatheter into the left middle cerebral artery, an SE FD with appropriate size was deployed to cover both aneurysms, achieving confirmed complete expansion and optimal wall apposition. Two hours postoperatively, the patient developed aphasia and hemiparesis. Subsequent angiography at 4 hours revealed thrombosis within the SE FD and fish mouthing at the proximal segment. Successful microguidewire traversal through the affected site restored complete FD expansion and wall apposition. Postoperatively, the patient's hemiparesis improved, and her motor aphasia resolved. Magnetic resonance imaging confirmed multiple acute infarctions, while computed tomography demonstrated proper FD expansion. At 3-month follow-up, near-normal functional recovery was observed. This case indicates that SE FD deployment may be complicated by acute ultra-early fish mouthing attributable to post-deployment tension release. Preventive strategies should emphasize appropriate device sizing, adequate landing zone selection, and post-implant tension assessment.},
}

@article {pmid41868729,
year = {2026},
author = {Sethi, N and Levy, OA and Richardson, A and Harari, OA and Sellati, R},
title = {A Qualitive Investigation of Geographic Disparities in Genetic Testing and Care Access for Amyotrophic Lateral Sclerosis: Insights From Patient Journey Mapping.},
journal = {Patient preference and adherence},
volume = {20},
number = {},
pages = {566747},
pmid = {41868729},
issn = {1177-889X},
abstract = {PURPOSE: Amyotrophic lateral sclerosis (ALS) is a progressive neuromuscular disease that is associated with a high patient burden, reduced lifespan, and reduced quality of life. People living with ALS (PLwALS) often experience delays in diagnosis of ~1 year, and while current treatment options can slow disease progression, improve quality of life, and offer modest benefits in functional decline, they do not reverse neuronal damage. Defining and understanding the experiences of PLwALS can help identify gaps and barriers to optimal care.

PATIENTS AND METHODS: This non-interventional study was intended to obtain insights on the patient experience from the perspective of PLwALS. We sought to develop an ALS patient journey map from initial presentation through to end-of-life care for 4 regions (North America, Asia-Pacific, Latin America, and Europe/Middle East/Africa). The map was based on results from a global audit of data sources (including publications, patient narratives, society guidelines, academic reports, industry white papers [n=104]), and one-to-one, 60-minute, semi-structured interviews with PLwALS (n=12) or those caring for PLwALS (n=2). The initial patient journey map was subsequently reviewed during 2 advisory sessions with patient advocates (7 PLwALS and 2 caregivers) in September and November 2023.

RESULTS: We identified several barriers and challenges that most impact PLwALS, caregivers, and clinicians, with many similarities but also some differences across the regions.

CONCLUSION: These insights will enable targeted improvements in education, personalized care, resource allocation, care coordination, policy development, and funding, ultimately improving patient outcomes.},
}

@article {pmid41869005,
year = {2025},
author = {Lorenz, J and Hawkins, S and McCarthy, B},
title = {Griffiths et al.'s Study of Psilocybin with Religious Professionals: A Theological Response from a Christian Perspective.},
journal = {Psychedelic medicine (New Rochelle, N.Y.)},
volume = {3},
number = {4},
pages = {202-206},
pmid = {41869005},
issn = {2831-4433},
abstract = {Griffiths et al.'s recent "Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions" is an important study in the literature on psychedelic medicine and religious experience. In this commentary on the study, we argue: (1) The study design's implicit presupposition of perennialism in its conception of mysticism burdens it with metaphysical and theological freight it doesn't need to support its hypothesis; and (2) Psychedelic usage in pursuit of mysticism, however construed, risks two pathologies-hyper-individualism and idolatry-that religious traditions and communities are well-positioned to counter.},
}

@article {pmid41870290,
year = {2026},
author = {Narayan, A and Neupane, K and Woodside, MT},
title = {Scalable assay to identify inhibitors of prion-like propagation of protein misfolding as potential therapeutics for neurodegeneration.},
journal = {Protein science : a publication of the Protein Society},
volume = {35},
number = {4},
pages = {e70535},
doi = {10.1002/pro.70535},
pmid = {41870290},
issn = {1469-896X},
support = {PJT-185931/CAPMC/CIHR/Canada ; //NSERC Banting Postdoctoral Fellowship/ ; //Alberta Innovates Postdoctoral Fellowship/ ; },
mesh = {*Superoxide Dismutase-1/chemistry/metabolism/antagonists & inhibitors ; *Protein Folding/drug effects ; Humans ; *Amyotrophic Lateral Sclerosis/drug therapy/metabolism ; *Prions/metabolism/chemistry/antagonists & inhibitors ; },
abstract = {Protein misfolding is linked to many neurodegenerative diseases. In some cases, misfolding can propagate through a prion-like mechanism whereby natively folded molecules are converted into more copies of the misfolded isoform. Prion-like propagation of misfolding is an attractive therapeutic target, but difficulties with assaying conversion directly and simply have severely limited efforts to find drugs targeting conversion of disease-related proteins. Here, we demonstrate a scalable enzymatic assay for testing potential inhibitors of prion-like conversion in superoxide dismutase-1 (SOD1), whose misfolding is linked to amyotrophic lateral sclerosis (ALS). We tested several small-molecule inhibitors of SOD1 aggregation to determine if they also inhibited prion-like conversion. We found that some compounds, like telbivudine and cisplatin, did indeed significantly delay conversion, but others, like baicalein and quercetin, had little effect. Surprisingly, some compounds, like two statins tested, actually accelerated conversion, suggesting that they might act to promote ALS progression. These results underline the fact that conversion and aggregation are distinct biophysical processes. The ability of the assay to identify compounds effective at delaying prion-like conversion holds out promise for applications in future drug discovery efforts that target propagated misfolding specifically.},
}

*Superoxide Dismutase-1/chemistry/metabolism/antagonists & inhibitors
*Protein Folding/drug effects
Humans
*Amyotrophic Lateral Sclerosis/drug therapy/metabolism
*Prions/metabolism/chemistry/antagonists & inhibitors

@article {pmid41870380,
year = {2026},
author = {Elhami Athar, M and Miller, JD and Lynam, DR},
title = {From controversy to confusion: A commentary on how Marcus et al.'s (2025) Psychopathic Boldness Scale further muddies the boldness construct.},
journal = {Psychological assessment},
volume = {38},
number = {4},
pages = {332-338},
doi = {10.1037/pas0001442},
pmid = {41870380},
issn = {1939-134X},
mesh = {Humans ; *Antisocial Personality Disorder/diagnosis/psychology ; *Psychometrics/standards ; *Psychiatric Status Rating Scales/standards ; Reproducibility of Results ; },
abstract = {The Psychopathic Boldness Scale (see record 2025-96918-001) is a newly developed 21-item self-report measure intended to assess boldness as it manifests within psychopathy. In this commentary, we raise concerns about the PBS's construct validity, particularly its conceptual and empirical overlap with antagonism-related traits. Drawing on theoretical analysis and results from Marcus et al., we evaluated how PBS items function relative to the Triarchic Psychopathy Measure. Intraclass correlations of overall correlational profiles revealed that the nomological network of the PBS more closely aligns with Triarchic Psychopathy Measure meanness than with boldness. Rather than clarifying the role of boldness within psychopathy, the PBS repackages maladaptive content typically captured by meanness/antagonism under the boldness label and results in a case of the jingle fallacy. We argue that this conflation undermines theoretical precision and sets the stage for a more difficult-to-integrate literature. (PsycInfo Database Record (c) 2026 APA, all rights reserved).},
}

Humans
*Antisocial Personality Disorder/diagnosis/psychology
*Psychometrics/standards
*Psychiatric Status Rating Scales/standards
Reproducibility of Results

@article {pmid41870498,
year = {2026},
author = {Strojny, A and Kiszka, P and Strojny, P},
title = {Rethinking escapism and escape: A cognitive perspective on the C-DOG model.},
journal = {Journal of behavioral addictions},
volume = {},
number = {},
pages = {},
doi = {10.1556/2006.2025.00357},
pmid = {41870498},
issn = {2063-5303},
abstract = {This commentary builds on Giardina et al.'s (2021, 2024) conceptualization of escapism and escape in the C-DOG model, highlighting unresolved definitional ambiguities. We argue that the distinction between these constructs cannot rely solely on pre-game intentions (expectation to return vs. remain) due to potential cognitive biases and self-deception, particularly among players with Gaming Disorder (GD). Drawing on goal systems theory and research on maladaptive gaming-related beliefs, we propose that the post-game outcome, successful return vs. persistent difficulty disengaging, offers a more reliable criterion. This perspective reframes escapism and escape as goal-driven processes shaped by experiential avoidance and motivational rigidity.},
}

@article {pmid41870813,
year = {2026},
author = {Upadhayay, S},
title = {Role of Pentacyclic Triterpenes in the Management of Neurological Disorders: An Insight into Molecular Mechanisms and Therapeutic Approaches.},
journal = {Molecular neurobiology},
volume = {63},
number = {1},
pages = {},
pmid = {41870813},
issn = {1559-1182},
mesh = {Humans ; Animals ; *Nervous System Diseases/drug therapy/metabolism ; *Pentacyclic Triterpenes/therapeutic use/pharmacology ; *Neuroprotective Agents/therapeutic use/pharmacology ; Signal Transduction/drug effects ; Oxidative Stress/drug effects ; },
abstract = {Neurological disorders represent major public health concerns globally, as they profoundly affect motor function, memory, and cognitive abilities, thus compromising patients' independence and quality of life. Despite extensive research, current treatment approaches predominantly offer palliative care, failing to hinder disease progression. The rising incidence of these disorders underscores an urgent necessity for more efficacious and disease-modifying therapies. According to findings, pentacyclic triterpenoids exhibit neuroprotective properties by inhibiting neuronal oxidative stress, neuroinflammation, apoptosis, and degeneration, making them promising candidates for targeting the underlying causes of neurodegeneration. Therefore, in this review, we explore natural and synthetic pentacyclic triterpenoids that exhibit neuroprotective effects by modulating signaling pathways, such as HMGB1, TLR4, NLRP3, NF-κB, Nrf2, PI3K, Akt, and CREB, which play crucial roles in regulating cell proliferation, differentiation, and neuronal plasticity. The present literature survey is performed by searching various keywords with several combinations: "pentacyclic triterpenes", "neurological disorders", Parkinson's Disease", "Huntington's Disease", "Alzheimer's Disease", "Multiple sclerosis", "Amyotrophic Lateral Sclerosis" "Epilepsy", "mitochondria dysfunction", "oxidative stress", "preclinical studies", "molecular mechanisms", and "clinical studies". Studies indicates that pentacyclic triterpenoids have a wide range of therapeutic potentials, current findings summarizes existing knowledge and examines the neuroprotective properties and potential molecular mechanisms of pentacyclic triterpenoids related with health benefits and neurological diseases. Available evidence suggests that pentacyclic triterpenoids possess the capacity to impede disease progression and may be beneficial in the treatment of neurological disorders. This review strengthens the understanding of pentacyclic triterpenoids and their molecular mechanisms, while also facilitating pharmaceutical discovery and development for neurodegenerative disorders.},
}

Humans
Animals
*Nervous System Diseases/drug therapy/metabolism
*Pentacyclic Triterpenes/therapeutic use/pharmacology
*Neuroprotective Agents/therapeutic use/pharmacology
Signal Transduction/drug effects
Oxidative Stress/drug effects

@article {pmid41870864,
year = {2026},
author = {Gomez, R and Brown, T and Zarate, D and Houghton, S and Stavropoulos, V},
title = {A Network Approach to the Association Between Emotional Regulation and ADHD Symptoms in Adults: Pathways between Difficulties in Emotional Regulation and ADHD Dimensions.},
journal = {The Psychiatric quarterly},
volume = {},
number = {},
pages = {},
pmid = {41870864},
issn = {1573-6709},
}

@article {pmid41862640,
year = {2026},
author = {Onwunma, J and Binsabaan, S and Allen, SP and Thanthirige, SR and Gaur, D and Sankaran, B and Wohlever, ML},
title = {ALS mutations disrupt self-association between the ubiquilin STI1 hydrophobic groove and internal placeholder sequences.},
journal = {The EMBO journal},
volume = {},
number = {},
pages = {},
pmid = {41862640},
issn = {1460-2075},
support = {R35 GM137904-01S2//HHS | National Institutes of Health (NIH)/ ; P30 GM124169-01//HHS | National Institutes of Health (NIH)/ ; CAREER Award 2343131//National Science Foundation (NSF)/ ; },
abstract = {Ubiquilins are molecular chaperones that play multifaceted roles in proteostasis, with point mutations in UBQLN2 leading to altered phase-separation properties and amyotrophic lateral sclerosis (ALS). Our mechanistic understanding of this essential process has been hindered by a lack of structural information on the STI1 domain, which is essential for ubiquilin chaperone activity and phase separation. Here, we present the first crystal structure of a ubiquilin-family STI1 domain bound to a transmembrane domain (TMD), and show that ALS mutations disrupt the STI1-TMD interaction. We further demonstrate that ubiquilins contain multiple conserved internal sequences that bind to the STI1 domain, including the PXX-repeat region that is a hotspot for ALS mutations. We propose that these placeholder sequences prevent solvent exposure of the STI1 hydrophobic groove and contribute to the multivalency that drives ubiquilin phase-separation. Together, this work provides a new paradigm for understanding how STI1 domains modulate ubiquilin chaperone activity and phase separation, and offers insights into the molecular basis of ALS pathogenesis.},
}

@article {pmid41863273,
year = {2026},
author = {Singh, DD},
title = {PROTAC-Based Therapeutics: From Design to Clinical Potential in Neurodegenerative Disease.},
journal = {Current neuropharmacology},
volume = {},
number = {},
pages = {},
doi = {10.2174/011570159X438970260115164001},
pmid = {41863273},
issn = {1875-6190},
abstract = {Neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and ALS, are characterized by a progressive loss of neuronal function and a direct correlation between their progression and proteins with misfolded and aggregated structures. Although significant efforts have been made, and various therapies are available for their treatment, they show only a modest beneficial response to their progression. The main reasons for this phenomenon can be correlated with a loss of target specificity, low permeability in crossing the BBB, and their ineffectiveness in clearing proteins from neurons. Within this therapeutic paradigm, proteolysis-targeting chimaeras, or PROTACS, have been identified as a novel therapeutic strategy. Unlike traditional smallmolecule inhibitors, PROTACS take advantage of the natural ubiquitin proteasome system to specifically degrade target proteins. At a molecular level, PROTACS consist of a ligand that specifically recognizes a target protein, a linker, and an E3 ligand-recruiting ligand that specifically recruits an E3 ligase. At a therapeutic level, this offers the advantage of catalytic protein degradation that should allow for reduced dosing. Preclinical studies carried out using neurodegenerative disease models have shown the potential for selective targeting of major pathologic proteins, such as tau, α- synuclein, TDP-43, and mHTT, which are crucial for pathogenesis. In addition, developments in the formulation of brain-permeable PROTACS, understanding of E3 ligase expression levels in the central nervous system, and application of iPSC-derived neuronal systems have contributed to rapid developments in this area. Although pharmacokinetic modification and degradation-specific approaches are still required, evidence suggests a major therapeutic potential for PROTAC-based approaches for the treatment of neurodegenerative disorders.},
}

@article {pmid41863275,
year = {2026},
author = {Singh, AK and Kush, A and Bhushan, B and Dhanawat, M and Sharma, PK},
title = {Targeting Autophagy with Bioactive Compounds: Therapeutic Potential in Neurodegenerative Disorders.},
journal = {Current neuropharmacology},
volume = {},
number = {},
pages = {},
doi = {10.2174/011570159X408653251130061347},
pmid = {41863275},
issn = {1875-6190},
abstract = {Neurodegenerative disorders (NDs), including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS), are characterized by the accumulation of misfolded proteins and impaired cellular clearance mechanisms. Autophagy, a critical lysosomedependent degradative pathway, plays a vital role in maintaining proteostasis and neuronal health. Dysregulation of autophagy has been implicated in the pathogenesis of multiple NDs, making it a promising therapeutic target. This review comprehensively examines the molecular mechanisms of autophagy and its dysfunction across major NDs. Furthermore, it highlights the potential of bioactive compounds such as flavonoids, alkaloids, polyphenols, and terpenoids to modulate autophagic flux, thereby promoting the clearance of toxic protein aggregates like amyloid-β, tau, and α- synuclein. Emerging strategies, including nanotechnology-based delivery systems, are also discussed for enhancing the bioavailability and efficacy of these compounds. The evidence suggests that pharmacological or natural induction of autophagy may alleviate neurodegenerative pathology, though context- and stage-specific modulation is essential. This work underscores the therapeutic promise of autophagy-enhancing bioactives and calls for further research into their clinical applications.},
}

@article {pmid41863659,
year = {2026},
author = {Mullick, S and Chakraborty, A and Porel, P and Nath, R and Chaudhary, P and Islam, A and Das, J and Pramanik, S and Panigrahy, UP and Sridhar, SB and Mondal, M and Debnath, B and Ashique, S},
title = {Decoding Neuroinflammatory Pathways: The Role of the CXCL12-CXCR4/CXCR7 Axis in ALS-Related Cognitive Impairment.},
journal = {Molecular neurobiology},
volume = {63},
number = {1},
pages = {},
pmid = {41863659},
issn = {1559-1182},
mesh = {Humans ; *Chemokine CXCL12/metabolism ; *Receptors, CXCR/metabolism ; *Amyotrophic Lateral Sclerosis/metabolism/complications/pathology ; Animals ; *Receptors, CXCR4/metabolism ; *Cognitive Dysfunction/metabolism ; *Signal Transduction/physiology ; *Neuroinflammatory Diseases/metabolism/pathology ; Inflammation/metabolism/pathology ; },
abstract = {Cognitive impairment (CI) and accelerating neuronal deterioration are hallmarks of amyotrophic lateral sclerosis (ALS). Under these circumstances a crucial molecular mechanism in the pathophysiology of CI has been identified: the CXC chemokine receptor type 7 (CXCR7)/CXC chemokine receptor type 4 (CXCR4)/Cysteine-X-cysteine chemokine ligand 12 (CXCL12) region. Research on ALS shows that the CXCR7/CXCR4/CXCL12 complex plays a role in the degeneration of motor neurons and the resulting cognitive decline. JAK/STAT, PI3K/AKT, MAPK, and other signaling pathways are among the ways the axis controls neuronal inflammation, synaptic remodeling, and neuronal maintenance in each of these scenarios. The CXC motif chemokine ligand 12 (CXCL12) and CXC chemokine receptor type 4 (CXCR4) axis is crucial for the start of the inflammatory mechanism because of their function in mediating the chemotaxis of inflammatory cells. By preventing the migration of inflammatory cells via CXCL12 in the inflammatory area, the response to inflammation can be prevented or reduced. Consequently, the development of CXCR4 antagonists has emerged as a cutting-edge strategy for inflammation treatment. Recent research suggests that managing this relationship could reduce cognitive deficits and offer neuroprotective benefits. According to the current review, the CXCL12/CXCR4/CXCR7 pathway may be a promising target for treating cognitive dysfunction in neurodegenerative disorder. It also emphasizes the need for additional research to completely comprehend its function and identify efficient treatments which may result in improved clinical treatment modalities for these debilitating illnesses.},
}

Humans
*Chemokine CXCL12/metabolism
*Receptors, CXCR/metabolism
*Amyotrophic Lateral Sclerosis/metabolism/complications/pathology
Animals
*Receptors, CXCR4/metabolism
*Cognitive Dysfunction/metabolism
*Signal Transduction/physiology
*Neuroinflammatory Diseases/metabolism/pathology
Inflammation/metabolism/pathology

@article {pmid41864292,
year = {2026},
author = {Liu, H and Zhu, J and Chen, Y and Lin, X and Hua, C and Chen, H},
title = {Response to Jia et al.'s "Comment on the "genetic classification helps with precise sirolimus treatment in slow-flow vascular malformations"".},
journal = {Journal of the American Academy of Dermatology},
volume = {},
number = {},
pages = {},
doi = {10.1016/j.jaad.2026.03.041},
pmid = {41864292},
issn = {1097-6787},
}

@article {pmid41864411,
year = {2026},
author = {Davias, A and Tang, IW and Hansen, J and Knekt, P and Rantakokko, P and Weisskopf, MG},
title = {Associations between pre-disease biomarkers of persistent organic pollutants and amyotrophic lateral sclerosis risk in four European cohorts.},
journal = {Environmental research},
volume = {},
number = {},
pages = {124337},
doi = {10.1016/j.envres.2026.124337},
pmid = {41864411},
issn = {1096-0953},
abstract = {OBJECTIVES: Previous retrospective studies suggested that occupational exposures to persistent organic pollutants (POPs) may be associated with amyotrophic lateral sclerosis (ALS), but prospective studies with biomarker exposure assessment are scarce. This study aimed to prospectively investigate the relationship between POP exposures and ALS risk in the Danish Diet, Cancer and Health study (EPIC) cohort and to conduct a meta-analysis including results from the prior study of 3 small prospective Finnish cohorts in addition to the Danish EPIC cohort.

METHODS: We identified 166 incident ALS cases between 1993 and 1997 using the Danish National Patient Register and randomly selected 334 controls by individual matching on birth-year and sex. Levels of 13 polychlorinated biphenyls, 9 organochlorine pesticides and 3 polybrominated diphenyl ethers were assessed from baseline plasma samples. We employed conditional logistic regression models using exposure quartiles, and generalized additive models (GAMs), adjusting for confounders. We conducted a meta-analysis combining 3 Finnish prospective cohorts with the Danish data using a random-effects model.

RESULTS: The Danish results suggested generally inverse trends between several POPs and the predicted ALS risk; especially for chlordane-related compounds (co-pollutant quartile model, p-value<0.01). GAMs supported these trends, although most were not statistically significant. However, hexachlorobenzene was positively associated with ALS risk in co-pollutant GAM (p-value=0.02). Additionally, the GAMs suggested higher ALS odds at the highest levels of exposure of some POPs, but the data at these levels was sparse. Meta-analysis results were mostly consistent with the Danish findings.

CONCLUSION: Our study suggested elevated ALS risk among those exposed to hexachlorobenzene when adjusting for co-pollutants. Higher level of some POPs suggested a positive association with ALS occurrence, but the data was scarce at these levels.},
}

@article {pmid41864543,
year = {2026},
author = {Wu, J and Ma, H and Niu, X and Zhang, Z and Guo, R and Shen, N and Tian, Y and Zhao, H and Yang, Y and Chen, Y},
title = {The p75NTR Signaling Axis: Bridging Neurodevelopmental Homeostasis, Pathological Mechanisms, and Therapeutic Strategies in Neurodegenerative Diseases.},
journal = {Ageing research reviews},
volume = {},
number = {},
pages = {103105},
doi = {10.1016/j.arr.2026.103105},
pmid = {41864543},
issn = {1872-9649},
abstract = {The neurotrophin receptor p75 (p75NTR) plays dual, context-dependent roles in the nervous system that are regulated by ligand binding, co-receptor interactions, and microenvironmental cues. During neurodevelopment, synaptic plasticity, and in neurodegenerative disorders, p75NTR orchestrates opposing cellular responses: it can support neuronal homeostasis through pro-survival pathways, while also initiating apoptotic and inflammatory cascades that exacerbate disease progression. In Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS), activation of p75NTR drives pathological processes such as neuronal apoptosis and axonal degeneration, leading to impaired cognitive and motor function.Importantly, different structural domains of p75NTR have divergent effects. The extracellular domain (p75ECD) exhibits neuroprotective properties in AD models, in contrast with the pro-apoptotic activity associated with the full-length receptor. Therapeutic targeting of p75NTR with small-molecule ligands and ROCK inhibitors has shown efficacy in preclinical models, and some candidates have progressed to clinical trials. However, several challenges hinder clinical translation: (1) the mechanisms underlying p75NTR upregulation are not fully understood; (2) its downstream signaling network is highly complex; and (3) existing biomarker systems remain limited.A comprehensive understanding of p75NTR's role in neurodegeneration may clarify pathological mechanisms and reveal novel therapeutic targets. Achieving this will require multidisciplinary collaboration to bridge the gap between basic research and clinical applications.},
}

@article {pmid41865815,
year = {2026},
author = {Liu, X and Gao, Z and Xu, J},
title = {Beyond Fluorescence: A Critical Look at AI-Powered Brightfield Analysis for T-Cell Killing Assays.},
journal = {SLAS discovery : advancing life sciences R & D},
volume = {},
number = {},
pages = {100307},
doi = {10.1016/j.slasd.2026.100307},
pmid = {41865815},
issn = {2472-5560},
abstract = {This comment evaluates dela Cruz-Chuh et al.'s AI-based label-free workflow for analyzing T-cell mediated tumor killing via brightfield imaging. The study's core strengths include eliminating fluorescent labeling artifacts, achieving comparable consistency to conventional segmentation-based methods, and accommodating phenotypically diverse cancer cells without manual parameter tuning-addressing key bottlenecks in immunotherapy screening. However, critical considerations persist: the binary "killing/non-killing" classification framework may insufficiently resolve low-level or partial cytotoxicity, as evidenced by six false negatives; generalizability to non-adherent hematological malignancies or alternative effector cells remains untested; and the model lacks interpretability regarding morphological features driving cytotoxicity predictions. Additionally, performance across variable imaging platforms or culture conditions is unevaluated, limiting translational reproducibility. Despite these gaps, the workflow advances high-throughput immunotherapy screening efficiency. Future studies incorporating multi-class training, validation across diverse cancer types, and mechanistic decoding of AI-predicted features will strengthen its rigor and broader applicability in drug discovery.},
}

@article {pmid41861969,
year = {2026},
author = {Kamar, N and Congy-Jolivet, N and Salhi, S and Darres, A and Colombat, M and Milhes, J and Esposito, L and Guy, P and Hebral, AL and Prudhomme, T and Sallusto, F and Pellegrini, J and Medrano, C and Marion, O and Del Bello, A},
title = {Anti-lymphocyte globulin versus anti-thymocyte globulin in kidney transplant patients with preformed donor specific antibodies.},
journal = {Transplant immunology},
volume = {},
number = {},
pages = {102375},
doi = {10.1016/j.trim.2026.102375},
pmid = {41861969},
issn = {1878-5492},
abstract = {State-of-the-art immunosuppressant therapies recommend the use of induction therapy after kidney transplantation. Anti-interleukin-2 receptor antibody (basiliximab) is used for low-risk patients whereas polyclonal anti-lymphocyte sera (ALS) are recommended for medium/high-risk patients. There are two commercially available rabbit-derived ALS, namely anti-thymocyte globulin (RATG; Thymoglobulin®) and anti-lymphocyte globulin (RATLG; Grafalon®). We retrospectively compared the efficacy and safety of RATG or RATLG induction therapy in high-risk kidney transplant recipients with preformed donor specific antibodies (DSAs; n = 124). Forty-seven recipients received 1.25 mg/kg RATG for 2 to 3 days. Seventy-seven recipients were treated with 9 mg/kg RATLG on day 0 followed by 4 mg/kg RATLG for 2 to 3 days (n = 21) or a single dose of 9 mg/kg RATLG on day 0 (n = 56). Overall there were no significant differences observed between patients treated with RATG and RATLG. Similarly, no difference was observed between patients who had been given a single dose of RATLG and multiple doses of RATLG or RATG. At one year, patient and graft survival rates, acute rejection rate and type of rejection, kidney function, infections and malignancies did not differ between groups. Kidney transplant patients with preformed DSA showed similar clinical outcomes when treated with RATG or RATLG induction therapy. Polyclonal antibodies in high immunological risk kidney transplant patients.},
}

@article {pmid41856848,
year = {2026},
author = {Wang, R and Chen, W},
title = {Comment on: "Clinical safety of ultra-high-dose methylcobalamin in patients with amyotrophic lateral sclerosis: Open-label extension of a phase 2/3 randomized controlled study".},
journal = {Journal of the neurological sciences},
volume = {},
number = {},
pages = {125791},
doi = {10.1016/j.jns.2026.125791},
pmid = {41856848},
issn = {1878-5883},
}

@article {pmid41858070,
year = {2026},
author = {Zhang, Z and Fan, R and Jing, S and Liu, S and Liu, L and Que, W and Lu, D and Gan, Y and Xiao, F},
title = {Plasma proteomic trajectories before the onset of neurodegenerative diseases.},
journal = {Neurodegenerative disease management},
volume = {},
number = {},
pages = {1-12},
doi = {10.1080/17582024.2026.2646760},
pmid = {41858070},
issn = {1758-2032},
abstract = {BACKGROUND: The study aimed to identify indicative proteins associated with the occurrence and mortality of three neurodegenerative diseases (NDDs) and track the changes of proteins before the onset of NDDs.

RESEARCH DESIGN AND METHODS: We analyzed plasma proteomic data from UK Biobank. Cox regression analyses were utilized to detect the relationship between plasma proteins and the risk of development and all-cause mortality of Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). Predictive models were established based on related proteins using Lasso regression.

RESULTS: We identified 14 disease-associated proteins for AD, 35 for PD, and one for ALS. The trajectory of plasma proteins before the onset of NDDs was portrayed. Neuroinflammation and the remodeling of the extracellular matrix might be common pathways for NDDs.

CONCLUSIONS: Our results highlighted that the landscape of plasma protein changes before the onset of NDDs.},
}

@article {pmid41858090,
year = {2026},
author = {Ellis, AC and Dobak, S and Pearson, K and McGuire, R and Sutton, T},
title = {Registered Dietitians' perspectives on nutrition management of persons living with amyotrophic lateral sclerosis.},
journal = {Neurodegenerative disease management},
volume = {},
number = {},
pages = {1-9},
doi = {10.1080/17582024.2026.2646759},
pmid = {41858090},
issn = {1758-2032},
abstract = {AIM: Persons with amyotrophic lateral sclerosis (PALS) are at high risk for malnutrition, which is a negative prognostic factor for disease progression and survival. This study explored the perspectives of Registered Dietitians (RDs) providing nutrition care to PALS, focusing on barriers and facilitators to optimal patient care.

METHODS: RDs from U.S. multidisciplinary ALS clinics participated in six virtual focus groups. Recordings were transcribed verbatim and independently coded by two researchers for deductive content analysis.

RESULTS: RDs highlighted the importance of using clinical judgment to assess nutrition status and individualizing recommendations to respect patient autonomy. The multidisciplinary team model was identified as a strong facilitator to optimal patient care, while insurance coverage for nutrition-related supplies was a common barrier. RDs reported having little prior knowledge of ALS before assuming their current roles and described the need to upskill through self-teaching and on-the-job experience.

CONCLUSIONS: Results emphasize the importance of clinical judgment with respect to patient autonomy in providing nutrition care to PALS. The barriers and facilitators identified across multiple levels provide insight for future interventions to improve patient care.},
}

@article {pmid41858403,
year = {2026},
author = {Chun, S and Woon Kim, G and Bit Kim, H},
title = {Association between on-scene cardiopulmonary resuscitation duration and outcomes in out-of-hospital cardiac arrest patients.},
journal = {World journal of emergency medicine},
volume = {17},
number = {2},
pages = {137-145},
pmid = {41858403},
issn = {1920-8642},
abstract = {BACKGROUND: Prolonged on-scene Advanced Life Support (ALS) in out-of-hospital cardiac arrest (OHCA) patients may enhance return of spontaneous circulation (ROSC), but the optimal duration of cardiopulmonary resuscitation (CPR) without initial prehospital ROSC remains unclear. We investigated the association between on-scene CPR duration and outcomes using nationwide data. METHODS: This prospective, multi-regional study (2015-2022) included medical cause OHCA patients who underwent Smart ALS (SALS). Data from emergency medical services (EMS) records, SALS logs, and hospital outcomes were analyzed. Logistic regression models were developed for prehospital ROSC, survival to discharge, and good neurological outcome (Cerebral Performance Category [CPC] 1-2). RESULTS: Among 98,569 patients, 34,989 were SALS-eligible and 16,052 received SALS. Predictors of ROSC included younger age, male sex, public arrest, witnessed arrest, bystander CPR, shockable rhythm, and shorter response/scene times. Longer on-scene CPR reduced probabilities of ROSC, survival, and neurological recovery at hospital discharge. Model AUROCs were 0.697 (95%CI 0.676-0.717) for ROSC, 0.836 (95%CI 0.810-0.861) for survival, and 0.925 (95%CI 0.904-0.946) for neurological outcome. CONCLUSION: On-scene CPR duration is a critical prognostic factor in OHCA. The proposed models highlight on-scene predictors that may inform decisions about CPR continuation and support individualized resuscitation strategies. External validation in other EMS systems is warranted.},
}

@article {pmid41858506,
year = {2026},
author = {Hier, DB and Carrithers, MD and Rodríguez-Fernández, JM and Kummer, B},
title = {Editorial: The digitalization of neurology-volume II.},
journal = {Frontiers in digital health},
volume = {8},
number = {},
pages = {1806851},
doi = {10.3389/fdgth.2026.1806851},
pmid = {41858506},
issn = {2673-253X},
}

@article {pmid41858744,
year = {2026},
author = {Jessee, S and Malhotra, N and Sen, M},
title = {Is the Supreme Court veering rightward? The ebb and flow of representation.},
journal = {PNAS nexus},
volume = {5},
number = {3},
pages = {pgag060},
pmid = {41858744},
issn = {2752-6542},
abstract = {Conducting novel surveys that allow the first direct comparisons between Supreme Court decisions and public preferences, Jessee et al. find that the Court moved sharply to the right between 2020 and 2021 and attribute this change to the replacement of Justice Ruth Bader Ginsburg with Justice Amy Coney Barrett. We extend Jessee et al.'s analysis by presenting additional data gathered between 2022 and 2025. We find that the Supreme Court maintained its conservative position in 2022 but then moderated in 2023 following the backlash to the decision in Dobbs v. Mississippi (2022), which repealed Roe v. Wade (1973). We show that despite the composition of the Court remaining stable and the identity of the median voter being unchanged between 2021 and 2025, there is an ebb and flow to the representativeness of Court decisions, with the institution sometimes further to the right of the public and then sometimes shifting closer to the average voter. However, despite these important periodic shifts, the Court has, since 2021, generally remained in a more conservative position relative to the ideological positioning of the American electorate. Our findings have important implications for the legitimacy of the Court and the stability of the rule of law.},
}

@article {pmid41858792,
year = {2026},
author = {Raber, J and Sharpton, TJ},
title = {Diet, gut microbiome, and cognition in neurodegeneration: a review and methodological framework.},
journal = {Frontiers in aging neuroscience},
volume = {18},
number = {},
pages = {1771904},
pmid = {41858792},
issn = {1663-4365},
abstract = {The gut microbiome influences brain function through the gut-brain axis via synthesis of neurotransmitters, production of metabolites affecting epithelial barrier integrity and immune modulation and signaling through the vagus nerve. In humans, microbiome diversity reflects healthy aging and predicts survival, while dysbiosis is increasingly implicated in neurodegenerative conditions including Alzheimer's disease, Parkinson's disease, multiple sclerosis, and ALS. Fecal transplant studies in germ-free mice demonstrate that microbiome alterations are sufficient to induce cognitive and neuropathological phenotypes, supporting causality in preclinical models. Genetic risk factors and environmental exposures affect both neurodegeneration risk and microbiome composition. In this review, we synthesize evidence from human cohorts and preclinical models on the gut-brain axis in cognitive health and disease. We then present a methodological framework for diet-microbiome-cognition research, addressing causal inference through mediation analysis, supervised approaches for deriving diet scores, validation strategies, and individual heterogeneity. This framework can guide development of microbiome-targeted dietary interventions to improve cognitive outcomes.},
}

@article {pmid41859232,
year = {2026},
author = {Sharbafshaaer, M and Pirozzi, MA and Caiazzo, G and Canale, F and Silvestro, M and Russo, A and Tessitore, A and Esposito, F and Trojsi, F},
title = {Subcortical microstructural impairment in amyotrophic lateral sclerosis: clinical correlates of neurite orientation dispersion and density imaging (NODDI) changes.},
journal = {Frontiers in neuroscience},
volume = {20},
number = {},
pages = {1757470},
pmid = {41859232},
issn = {1662-4548},
abstract = {INTRODUCTION: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease involving widespread network disruption beyond the motor cortex. Deep gray matter (DGM) nuclei, crucial for motor and cognitive integration, remain underexplored in vivo. This study applied neurite orientation dispersion and density imaging (NODDI) to evaluate DGM microstructure and its relationship with clinical disability in ALS.

METHODS: Diffusion-weighted MRI data were acquired from 23 ALS patients and 24 age- and sex-matched healthy controls. Orientation dispersion index (ODI), neurite density index (NDI), and free water fraction (FWF) were extracted from the bilateral thalamus, caudate, putamen, pallidum, hippocampus, and amygdala using the Destrieux atlas. Group comparisons and partial correlations were adjusted for age, sex, and disease duration.

RESULTS: No significant group differences in DGM volumes or NODDI-derived metrics survived correction for multiple comparisons. Within the ALS group, several nominal (uncorrected) associations were observed between DGM microstructural metrics and ALSFRS-R subscores. Reduced respiratory subscores were associated with higher ODI in the left thalamus (ρ = 0.57, p = 0.0047, uncorrected). Fine-motor subscores showed nominal positive associations with ODI in the left (ρ = 0.48, p = 0.021, uncorrected) and right amygdala (ρ = 0.51, p = 0.012, uncorrected). Gross motor subscores were nominally associated with NDI in the right thalamus (ρ = 0.58, p = 0.004, uncorrected), left thalamus (ρ = 0.42, p = 0.047, uncorrected), left caudate (ρ = 0.52, p = 0.011, uncorrected), and right caudate (ρ = 0.57, p = 0.033, uncorrected). None of these associations survived false discovery rate correction and should therefore be interpreted as exploratory.

DISCUSSION: These findings suggest subtle and predominantly exploratory associations between DGM microstructural properties and clinical measures in ALS. NODDI derived metrics, particularly ODI and NDI, may provide sensitive indices of subcortical microstructural variation, warranting further investigation in larger cohorts.},
}

@article {pmid41860162,
year = {2026},
author = {Mak, SS and McManus, P and Greer, S and Haws, K and Carlson, CJ and Chandler, HK and Osinubi, O and Ash, GI},
title = {Deployment of an Activity Monitoring Program to Complement a Clinical Intervention for Veterans With Gulf War Illness: Qualitative Study.},
journal = {JMIR human factors},
volume = {13},
number = {},
pages = {e82177},
doi = {10.2196/82177},
pmid = {41860162},
issn = {2292-9495},
mesh = {Humans ; *Veterans/statistics & numerical data/psychology ; *Persian Gulf Syndrome/therapy ; Male ; Qualitative Research ; Middle Aged ; Female ; Adult ; Feasibility Studies ; United States ; },
abstract = {BACKGROUND: Many veterans who served in the Gulf experience Gulf War Illness (GWI), a chronic multisymptom condition associated with fatigue, pain, gastrointestinal problems and respiratory issues, mood/cognitive issues, and sleep difficulties. These symptoms contribute to decreased function, increased mental health needs, and poor quality of life. The Veterans Affairs War Related Illness and Injury Study Center in New Jersey developed a 26-week virtual health coaching intervention to support symptom management for veterans with GWI. In 2023, a consumer-grade smartwatch was added as part of an activity monitoring program to complement this program.

OBJECTIVE: The purpose of this project was to assess the feasibility and acceptability of including a smartwatch-based activity monitoring component to complement a virtual health coaching program for veterans with GWI.

METHODS: Twenty-four veterans enrolled in the health coaching program were invited to participate in the activity monitoring component. Participants attended a virtual orientation to set up the smartwatch, and verbal consent to share data through a Health Insurance Portability and Accountability Act (HIPAA)-compliant platform was obtained. Program feasibility was assessed by evaluating wear-time percentage and duration of use. Acceptability was assessed using two items from a monthly survey and through a midprogram semistructured interview. Quantitative data were summarized descriptively, and qualitative data were analyzed using a coding scheme adapted from Sekhon et al's Theoretical Framework for Acceptability (TFA).

RESULTS: Twenty veterans agreed to participate in the program (mean age 49 years; 7/20, 35% female; 19/20, 94% non-Hispanic White; 11/20, 55% first-time smartwatch users). Twelve participants (60%) wore the watch for the full 26 weeks. Among participants who completed 26 weeks, median daily wear-time completeness exceeded 80% for 25 weeks. Most participants (12/20, 60%) reported that wearing the smartwatch helped them achieve their wellness goals, and the majority (16/20, 80%) said they would recommend using the smartwatch for activity monitoring to other veterans. Qualitative findings supported acceptability across TFA domains. One adverse event was reported (minor skin irritation that resolved after changing the smartwatch band to a hypoallergenic watch band).

CONCLUSIONS: Within this clinical program, pairing a smartwatch with virtual health coaching for veterans with GWI was feasible and acceptable. Activity monitoring integrated into an existing intervention may support symptom self-management and augment patient education and engagement. As no prior activity monitoring programs specific to veterans with GWI have been described, these findings could inform future program development and implementation within this population.},
}

Humans
*Veterans/statistics & numerical data/psychology
*Persian Gulf Syndrome/therapy
Male
Qualitative Research
Middle Aged
Female
Adult
Feasibility Studies
United States

@article {pmid41860208,
year = {2026},
author = {Pirdankar, OH and Nene, AS and Thakur, R and Shah, S and Shenoy, P and Badole, P},
title = {Intravitreal Anti-vascular Endothelial Growth Factor in Retinopathy of Prematurity: A Bibliometric Analysis.},
journal = {Journal of pediatric ophthalmology and strabismus},
volume = {},
number = {},
pages = {1-10},
doi = {10.3928/01913913-20251106-02},
pmid = {41860208},
issn = {1938-2405},
abstract = {Retinopathy of prematurity (ROP) is one of the leading cause of blindness in premature infants. A bibliometric analysis on intravitreal anti-vascular endothelial growth factor (VEGF) in ROP was conducted. A comprehensive search of the article on the Scopus database was conducted with the terms related to "anti-vascular endothelial growth factor and retinopathy of prematurity." Only original research and review articles published in the English language were considered. VOSviewer version 1.6.20 was used for the visualization and analysis of the data. Publication trend, productive countries, researchers' details, commonly cited documents, source and influential journals, and keyword occurrence were analyzed. A total of 329 studies were considered, of which 270 were original articles and 59 were review articles. The highest numbers of publications were seen in the year 2022. The United States, China, Turkey, India, and Taiwan were the top 5 countries that published research on the use of anti-VEGF in ROP. The most documents were published by Wei-Chi Wu (22) and Chi-Chun Lai (14), and Falavarjani et al's article had the most citations (737). A total of 2,504 keywords were identified. All keyword analysis revealed the occurrence of "retinopathy of prematurity" and "human" as a keyword was 290 and 286 times, respectively. Most articles and citations were found in Retina. The use of anti-VEGF in ROP is constantly evolving and bibliometric analysis highlights a research trend and influential authors and journals that have published significant work on it. This article can serve as a guide to conduct a literature review for future researchers.},
}

@article {pmid41860259,
year = {2026},
author = {Burt-Oberecken, N and Megat, S and Rouaux, C},
title = {[Protective effect of a CREB3 gain-offunction variant in amyotrophic lateral sclerosis].},
journal = {Medecine sciences : M/S},
volume = {42},
number = {3},
pages = {234-237},
doi = {10.1051/medsci/2026027},
pmid = {41860259},
issn = {1958-5381},
}

@article {pmid41860888,
year = {2026},
author = {Bao, S and Bajet, A and Martínez, R and Müller-Trede, J and Engeler, I and Hafenbrädl, S},
title = {Commentary: On the Equal-Opportunity Jerk "Defense": Rudeness Complicates Sexism Attributions but Comes at a Cost.},
journal = {Psychological science},
volume = {},
number = {},
pages = {9567976261418939},
doi = {10.1177/09567976261418939},
pmid = {41860888},
issn = {1467-9280},
abstract = {Sexism is a pervasive and persistent problem. In their 2022 article "The 'Equal-Opportunity Jerk' Defense: Rudeness Can Obfuscate Gender Bias" (Psychological Science, Vol. 33, pp. 397-411), Belmi et al. argued that sexism can be obfuscated and go unpunished if perpetrators also act rudely toward men: the "equal-opportunity jerk defense." We introduce a simple Bayesian model that accounts for Belmi et al.'s findings and corroborated their predictions and implications in five preregistered experiments (N = 6,968 U.S. adults recruited via Prolific). We replicated that being rude toward men decreased perceived sexism but importantly found that it came at the cost of increased punishment (Study 1). Moreover, rudeness primarily decreased actors' perceived sexism, whereas their actions were still perceived as sexist (Study 2). Sexism ratings were sensitive to prior beliefs about the prevalence of sexism and to the diagnosticity of observed sexist behavior (Supplementary Studies S1-S2), in line with a broader Bayesian perspective. Bias in sexism ratings thus need not implicate fallacious cognitive processes or an "illusion of gender blindness."},
}

@article {pmid41861112,
year = {2026},
author = {Fu, P and Zhang, X and Zhou, Y and Zheng, J and Sun, A and Zhuang, K and Bao, W and Gao, G},
title = {Embedded CRISPRi Enhances Gene-Silencing Efficiency in Drosophila.},
journal = {Advanced science (Weinheim, Baden-Wurttemberg, Germany)},
volume = {},
number = {},
pages = {e15849},
doi = {10.1002/advs.202515849},
pmid = {41861112},
issn = {2198-3844},
support = {32500494//National Natural Science Foundation of China/ ; 32370631//National Natural Science Foundation of China/ ; //priority academic program development of jiangsu higher education institutions/ ; },
abstract = {CRISPR interference (CRISPRi), leveraging catalytically inactive Cas9 (dCas9), has transformed transcriptional silencing. However, its application in Drosophila melanogaster has been constrained by inconsistent efficiency and limited repression amplitude. Here, we present embedded CRISPR interference (emCRISPRi), an advanced gene-silencing platform that integrates transcriptional repression domains (Mxi and TRD) into a structurally flexible region of dCas9. This design significantly enhances silencing efficiency, enabling robust repression of coding genes and cis-regulatory elements, particularly at transcription start site (TSS)-proximal regions. emCRISPRi demonstrates improved gene-silencing activity compared to RNA interference (RNAi) at several tested loci and facilitates strong phenotypic rescue via unmodified cDNA. Its versatility is demonstrated through the dissection of Hippo pathway interactions and the mitigation of TDP-43-induced neurotoxicity in an amyotrophic lateral sclerosis (ALS) model. These findings position emCRISPRi as a transformative tool for functional genomics, enhancer studies, and disease modeling in Drosophila, with significant potential for cross-species adaptation and therapeutic innovation.},
}

@article {pmid41861506,
year = {2026},
author = {Oka, S and Yamazaki, T and Takefuji, Y},
title = {Breaking the spline: Why distributed lag non-linear models miss thresholds in environmental psychiatry.},
journal = {Psychiatry research},
volume = {360},
number = {},
pages = {117104},
doi = {10.1016/j.psychres.2026.117104},
pmid = {41861506},
issn = {1872-7123},
abstract = {This critique evaluates Monti et al.'s investigation into associations between air pollution, apparent temperature, and schizophrenia severity. While their findings indicate significant short‑ and medium‑term effects of PM10 and thermal stress on PANSS scores, several methodological limitations warrant caution. Their study relies on residential exposure assignments, which may not capture individual mobility or indoor environments, potentially introducing substantial exposure misclassification. Despite appropriately modeling delayed and non-linear effects, the DLNM's reliance on predefined spline structures may oversimplify the complex, synergistic interactions among atmospheric variables. Seasonal discrepancies-such as the absence of PM10 effects in autumn-winter-may reflect unmodeled dependencies or limited pollutant data, particularly for PM2.5 and black carbon. To address these constraints, future research should incorporate flexible, data‑driven approaches, particularly those capable of uncovering latent structures within environmental mixtures. Unsupervised feature‑clustering methods can identify correlated pollutant groupings and reduce dimensional noise, while rank‑based correlation metrics provide robust assessment of non‑linear dependencies that are often obscured by parametric spline specifications. These non‑parametric techniques can complement DLNM by capturing multivariate synergies and interaction patterns that rigid basis structures may overlook. Overall, integrating such approaches is essential for advancing analytical capacity and improving risk assessment for vulnerable psychiatric populations.},
}

@article {pmid41851044,
year = {2026},
author = {Takeda, T and Ishikawa, A and Kokubun, S and Saito, Y and Isose, S and Ito, K and Arai, K and Kuwabara, S and Honda, K},
title = {Reduced nuclear TDP-43 and cytoplasmic DLK1 as markers of motor neuron degeneration in amyotrophic lateral sclerosis.},
journal = {Journal of neuropathology and experimental neurology},
volume = {},
number = {},
pages = {},
doi = {10.1093/jnen/nlag017},
pmid = {41851044},
issn = {1554-6578},
abstract = {Loss of upper and lower motor neurons (MNs) is a defining pathological feature underlying the clinical manifestations of amyotrophic lateral sclerosis (ALS). However, the differences in MN loss and TDP-43 pathology between these areas in ALS patients remain unclear. This study included 7 patients with ALS and 3 controls from consecutive autopsies. The cell density and regional density of TDP-43-positive inclusions in 4 upper MN areas and their anatomically corresponding lower MN areas were measured. The numbers of large cells with loss of nuclear TDP-43 and cytoplasmic delta-like-1 homolog (DLK1) were counted. The results showed severe MN loss in both upper and lower MN areas. However, TDP-43-positive inclusions differed markedly, that is they were rare in upper MNs but abundant in lower MN. In upper MN areas, TDP-43 density was not associated with the residual rate of MNs, whereas in lower MN areas, the density in MNs was associated with the cell residual rate. Significantly higher numbers of MNs lacking nuclear TDP-43 and cytoplasmic DLK1 were observed in the upper and lower MN regions in ALS vs controls. These findings suggest that these morphological changes may be closely related to motor neuron vulnerability and may be mechanistic contributors to ALS development.},
}

@article {pmid41851249,
year = {2026},
author = {Leinders, S and Aarnoutse, EJ and Branco, MP and Freudenburg, ZV and Geukes, SH and Schippers, A and Verberne, MSW and van den Boom, MA and van der Vijgh, BH and Crone, NE and Denison, T and Ramsey, NF and Vansteensel, MJ},
title = {Implanted brain-computer interface functionality during nighttime in late-stage amyotrophic lateral sclerosis.},
journal = {Scientific reports},
volume = {},
number = {},
pages = {},
doi = {10.1038/s41598-026-44228-7},
pmid = {41851249},
issn = {2045-2322},
support = {UH3NS114439/NS/NINDS NIH HHS/United States ; ADV 320708/ERC_/European Research Council/International ; UGT7685//Nederlandse Organisatie voor Wetenschappelijk Onderzoek/ ; U01DC016686/DC/NIDCD NIH HHS/United States ; },
abstract = {Brain-computer interfaces (BCIs) hold promise as assistive communication technology for people with severe paralysis. Although such BCIs should be available 24/7, feasibility of nocturnal BCI use has not been investigated. Here, we addressed this question using data from an electrocorticography-BCI user with amyotrophic lateral sclerosis. We investigated nocturnal dynamics of neural signal features used for BCI control. Additionally, we assessed nocturnal performance of a decoder trained on daytime data, by quantifying the number of unintentional BCI activations at night. Finally, we developed a nightmode functionality and assessed its performance. Mean and variance of low and high frequency band power were significantly higher at night than during the day. When applied to night data, daytime decoders caused unintentional BCI activations in 100% of nights (245 unintended click-commands and 13 unintended caregiver-calls per hour). The specifically developed nightmode functionality, however, functioned error-free in 79% of nights over a period of ± 1.5 years, allowing the user to reliably call the caregiver. Reliable nighttime use of a BCI requires strategies to adjust to circadian and sleep-related signal changes. This demonstration of a reliable nightmode and its long-term use by an individual with amyotrophic lateral sclerosis underscores the importance of 24/7 BCI reliability.},
}

@article {pmid41851271,
year = {2026},
author = {Hodgson, RE and Huang, WP and Lang, R and Kumar, V and An, H and Stender, EGP and Chalakova, ZP and Driver, MD and Sanchez Avila, A and Ellis, BCS and Day, E and Rayment, JA and Baeg, K and Strange, A and Moll, T and Wright, GSA and van Vugt, JJFA and , and Allen, SP and Locker, N and Pitout, I and Fletcher, S and Onck, PR and Duss, O and Cooper-Knock, J and Shelkovnikova, TA},
title = {Paraspeckle condensation is controlled via TDP-43 polymerization and linked to neuroprotection.},
journal = {Nature cell biology},
volume = {},
number = {},
pages = {},
pmid = {41851271},
issn = {1476-4679},
support = {MR/W004615/1//Research Councils UK (RCUK)/ ; MR/W028522/1//RCUK | Medical Research Council (MRC)/ ; BB/V014110/1//RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)/ ; PhD studentship//Motor Neurone Disease Association (MNDA)/ ; 969-799//Motor Neurone Disease Association (MNDA)/ ; PhD studentship//MND Scotland (Motor Neuron Disease Scotland)/ ; },
abstract = {The paraspeckle is a disease-relevant biomolecular condensate assembled from long non-coding RNA (lncRNA) NEAT1_2 ribonucleoprotein particles. Paraspeckle biogenesis is suppressed in normal tissues, yet it can be rapidly upregulated under stress. Here we demonstrate that a neurodegeneration-linked RNA-binding protein TDP-43 inhibits NEAT1_2 ribonucleoprotein particle condensation into the paraspeckle, in a concentration-dependent manner, which requires its intact polymerization and RNA binding. This effect is counterbalanced by core paraspeckle proteins such as FUS. Below disruptive concentrations, TDP-43 can be recruited into paraspeckles, forming non-liquid clusters. Under stress, TDP-43 sequestration into de novo nuclear condensates alleviates paraspeckle suppression and increases their dynamism. NEAT1_2 middle-part and 3'-end UG repeats mediate paraspeckle regulation by TDP-43 cotranscriptionally and post assembly, respectively. The deletion of the 3'-end UG repeat increases paraspeckle stability and cytoprotection in stressed human neurons. Consistently, longer 3'-end UG repeats are linked to shorter survival in the neurodegenerative disease amyotrophic lateral sclerosis. Thus, TDP-43 is a critical regulator of paraspeckle condensates linked to cytoprotection.},
}

@article {pmid41851470,
year = {2026},
author = {Michaelis, T and Lindestam Arlehamn, CS and Johansson, E and Frazier, A and Williams, GP and Berry, JD and Cudkowicz, M and Goyal, NA and Fournier, C and Snyder, A and Kwan, JY and Crook, J and Phillips, EJ and Mallal, SA and Ravits, J and Marder, KS and Sidney, J and Sulzer, D and Sette, A},
title = {Author Correction: Autoimmune response to C9orf72 protein in amyotrophic lateral sclerosis.},
journal = {Nature},
volume = {},
number = {},
pages = {},
doi = {10.1038/s41586-026-10388-9},
pmid = {41851470},
issn = {1476-4687},
}

@article {pmid41852184,
year = {2026},
author = {Gagliardi, D and Villella, C and Zanovello, M and Iacobelli, V and Corti, S and Comi, GP and Fratta, P and Houlden, H and Tucci, A and Ronchi, D},
title = {High Prevalence of SOD1 Pathogenic Variants in the UK Biobank: Implications for Early Intervention in Amyotrophic Lateral Sclerosis.},
journal = {Annals of neurology},
volume = {},
number = {},
pages = {},
doi = {10.1002/ana.78195},
pmid = {41852184},
issn = {1531-8249},
support = {//Italian Ministry of Health/ ; MR/Z506503/1//UK Medical Research Council/ ; MR/S006753/1//UK Medical Research Council/ ; },
abstract = {OBJECTIVE: SOD1 is the second most frequently mutated gene in European patients with amyotrophic lateral sclerosis (ALS). Given the recent authorization of SOD1-targeted antisense oligonucleotides for SOD1-ALS, prompt screening for SOD1 mutations in patients with ALS patients is highly recommended. Large-scale genomic analysis could inform on the population-based prevalence of SOD1 mutation carriers, who would potentially benefit from treatment. We aim to determine the number of people with pathogenic SOD1 variants in the UK Biobank (UKB), to address a critical gap between clinical and genetic prevalence of SOD1-ALS.

METHODS: We analyzed SOD1 variants within exome sequencing data from 470,000 individuals aged over 40 years. Pathogenicity was evaluated using referenced databases and American College of Medical Genetics and Genomics (ACMG) guidelines. Leveraging the UKB carrier frequency and age at onset data, we estimated the genetic prevalence of SOD1-ALS. We examined factors that may influence penetrance.

RESULTS: We identified 122 individuals with monoallelic SOD1 coding variants, 93.4% of whom were asymptomatic. Additionally, the low-penetrance p.Asp91Ala variant was observed in heterozygosis in 535 subjects, whereas it was never found in homozygosis. Excluding this variant, the expected number of people developing SOD1-ALS is 1.04:100,000 in the UK population, 4 times higher than clinically reported figures. Symptomatic carriers had significantly increased levels of serum neurofilament at baseline. Age-related penetrance was higher in non-p.Asp91Ala carriers versus p.Asp91Ala carriers. Long-term survivor status was associated with p.Asp91Ala genotype, older age, and lower neurofilament levels.

INTERPRETATION: Incomplete and age-related penetrance, along with underascertainment due to disease heterogeneity and limitations in data collection, likely account for the reduced number of symptomatic patients identified. Our findings highlight the need to identify genetic and environmental factors, as well as biological indicators, able to influence disease penetrance and phenoconversion risk in presymptomatic carriers and to predict treatment response in patients. ANN NEUROL 2026.},
}

@article {pmid41852280,
year = {2026},
author = {Isik, FI and Pickford, R and Timmins, HC and Piguet, O and Halliday, GM and Kiernan, MC and Kim, WS},
title = {Systemic dysregulation of apolipoproteins in amyotrophic lateral sclerosis serum.},
journal = {FEBS open bio},
volume = {},
number = {},
pages = {},
doi = {10.1002/2211-5463.70232},
pmid = {41852280},
issn = {2211-5463},
support = {IM-202303-00957//FightMND/ ; },
abstract = {Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by progressive motor neuron degeneration. Increasing evidence implicates systemic lipid perturbation in ALS pathogenesis. However, the extent and nature of apolipoprotein changes underlying lipid perturbations in ALS remain largely unknown. To address this, we performed a comprehensive analysis of major apolipoproteins involved in lipid metabolism and examined their association with lipoprotein membrane lipids in sporadic ALS (n = 32) and age-matched healthy controls (n = 32), using ELISA and liquid chromatography-mass spectrometry. Compared with controls, serum levels of apoB, apoCI, apoCII, apoCIII and apoE were significantly elevated in ALS, whereas apoAI and apoAII were unchanged. Distributional analyses demonstrated a relative decrease in apoAI and an increase in apoB in ALS, resulting in an elevated apoB/apoAI ratio, a marker of atherogenic risk, alongside a reduced apoAI/apoE ratio. Correlation analyses revealed strengthened interrelationships among apolipoproteins in ALS, suggesting altered regulatory coordination. At the lipid level, phosphatidylcholine (PC) was increased, whereas sphingomyelin (SM) was reduced in ALS serum. Notably, the strong associations of apoB to both PC and SM observed in controls were absent in ALS. Biomarker analyses identified apoE as the strongest discriminator between ALS and control groups. Collectively, these findings demonstrate a coordinated disruption of apolipoproteins and lipoprotein-associated lipids in ALS serum, with likely functional consequences for lipoprotein metabolism. This study provides new insights into lipid dysregulation in ALS pathobiology and supports the emerging view that ALS encompasses not only neurodegenerative processes but also systemic metabolic reprogramming.},
}

@article {pmid41852613,
year = {2026},
author = {Montesanti, S and Bradley, N and Demedeiros, S and McKay, R},
title = {Designing for implementation: a cognitive task analysis of intimate partner violence screening in hospital trauma care in Alberta, Canada.},
journal = {Frontiers in health services},
volume = {6},
number = {},
pages = {1743548},
pmid = {41852613},
issn = {2813-0146},
abstract = {BACKGROUND: Intimate partner violence (IPV) has serious health consequences, yet routine IPV screening remains inconsistently implemented in hospital trauma centres. Despite evidence supporting screening, implementation challenges persist. This study used Cognitive Task Analysis (CTA) to examine how trauma care providers perceive and enact IPV screening, with attention to cognitive processes, barriers, and facilitators to implementation.

METHODS: We conducted CTA group interviews with nine trauma care providers from two trauma centers in Edmonton, Alberta, Canada. Participants included trauma surgeons, nurse practitioners, social workers, and patient care managers. Using a structured interview guide and concept mapping techniques, we elicited knowledge structures, decision-making processes, and perceived constraints related to IPV screening. We applied an interpretive qualitative approach to uncover underlying themes related to cognitive work and task complexity. Grounded theory techniques, such as open and axial coding, were used in conjunction with CTA to analyze how participants reasoned through clinical scenarios. We paid close attention to how providers assessed cues, coordinated across roles, shifted priorities, and navigated organizational constraints. This hybrid approach allowed us to bridge systems-level implementation science with cognitive insights, drawing conceptually on CFIR and Proctor et al.'s implementation outcomes to generate actionable knowledge for IPV screening interventions in trauma care settings.

RESULTS: Themes were synthesized into six overarching cognitive domains: trauma care workflow, team collaboration and knowledge, critical situations and decision-making, IPV screening practices and challenges, understanding patient experiences, and institutional support. These were further illustrated through refined concept maps that visually represented participants' mental models, task sequences, and decision-making strategies.

CONCLUSION: Trauma care providers are well-positioned to identify IPV, yet screening is constrained by limited institutional support, unclear procedures, and poor integration into trauma workflows. Findings highlight the need for system-level strategies that align IPV screening with the cognitive and organizational realities of trauma care. By applying CTA, this study informs the design and implementation of context-sensitive IPV screening interventions that are more acceptable, appropriate, and feasible in hospital trauma settings. Furthermore, this study informs implementation strategies for integrating IPV screening interventions into trauma care, with particular implications for improving the acceptability, appropriateness, feasibility, and sustainability of evidence-based practices.},
}

@article {pmid41853322,
year = {2026},
author = {Elshaer, A and Thomas, L},
title = {Investigating inequality in Advanced Life Support courses: a retrospective, single-centre, survey-based pilot study.},
journal = {Resuscitation plus},
volume = {28},
number = {},
pages = {101283},
pmid = {41853322},
issn = {2666-5204},
abstract = {BACKGROUND: With more International Medical Graduates (IMGs) joining the United Kingdom's medical workforce, the demand for Advanced Life Support (ALS) courses has increased. Whilst differential attainment among IMGs is well-documented, little is understood about this phenomenon in ALS courses. This study explores the relationship between ALS course participants' background and course outcomes.

METHODS: Doctors who attended ALS courses at a UK course centre were retrospectively recruited to participate in a 28-question online survey about their language, education and clinical backgrounds, as well as their ALS course experience and outcomes. Quantitative and qualitative analyses were carried out, and recommendations were thematically summarised.

RESULTS: Of 419 invited healthcare professionals, 38 doctors (9%) completed the survey. 27 (71.1%) of the respondents graduated outside the UK, 32 (84.2%) studied medicine in English, and 15 (39.5%) were native English speakers. Passing the Cardiac Arrest Simulation Tests (CAS-Test) was statistically associated with more previous scenario-based simulation experience. Thematic analysis of responses suggested that biased treatment, language barriers, communication anxiety, inadequate undergraduate training, vulnerability, rigid professionalism and psychological insecurity were obstacles to IMGs attaining course outcomes. Suggestions for improvement focused on enhancing course accessibility, learning materials, the educational environment, assessment, and faculty development.

CONCLUSIONS: This exploratory study investigates IMGs' self-reported challenges and proposes interventions to promote the inclusivity of ALS courses. Further prospective research is required to evaluate the nature and generalisability of these findings and the applicability of the offered recommendations.},
}

@article {pmid41853978,
year = {2026},
author = {Piotrowski, SL and Allnutt, MA and Johnson, K and Tanaka, T and Ferrucci, L and Morris, H and Hardy, J and , and Ryten, M and , and Logroscino, G and Troncoso, J and Beach, TG and Serrano, GE and Cruchaga, C and Dickson, DW and Ross, OA and Chiò, A and , and , and Houlden, H and , and Dalgard, CL and Ding, J and Gibbs, JR and Traynor, BJ and Scholz, SW and Jacobson, S},
title = {Herpesvirus genome integration in whole-genome sequences of dementia and control cohorts.},
journal = {Alzheimer's & dementia : the journal of the Alzheimer's Association},
volume = {22},
number = {3},
pages = {e71047},
doi = {10.1002/alz.71047},
pmid = {41853978},
issn = {1552-5279},
support = {1ZIAAG000935/AG/NIA NIH HHS/United States ; P30AG019610/AG/NIA NIH HHS/United States ; P30AG072980/AG/NIA NIH HHS/United States ; U24AG021886/AG/NIA NIH HHS/United States ; P50AG016574/AG/NIA NIH HHS/United States ; U19AG071754/AG/NIA NIH HHS/United States ; R01AG087165/AG/NIA NIH HHS/United States ; U24 NS072026/NS/NINDS NIH HHS/United States ; 1ZIANS003154/NS/NINDS NIH HHS/United States ; U54-NS110435/NS/NINDS NIH HHS/United States ; P50NS072187/NS/NINDS NIH HHS/United States ; 211002//Arizona Department of Health Services/ ; 4001 0011 05-901//Arizona Biomedical Research Commission/ ; //Michael J. Fox Foundation for Parkinson's Research/ ; //Ted Turner and family/ ; //Little Family Foundation/ ; //Mayo Clinic Dorothy and Harry T. Mangurian Jr. Lewy body dementia program/ ; },
mesh = {Humans ; *Dementia/virology/genetics ; *Genome, Viral/genetics ; *Herpesvirus 6, Human/genetics ; *Virus Integration/genetics ; Cohort Studies ; Whole Genome Sequencing ; Aged ; Female ; Male ; *Herpesviridae/genetics ; Alzheimer Disease/virology/genetics ; },
abstract = {INTRODUCTION: The infectious hypothesis suggests that microbes like herpesviruses may play a role in the pathogenesis of Alzheimer's disease (AD) and other related dementias through methods that may include viral genome integration. The occurrence of herpesvirus genome integration in dementia patients has not been thoroughly characterized.

METHODS: Over 7500 total whole-genome sequences from control, frontotemporal dementia/amyotrophic lateral sclerosis spectrum, Lewy body dementia (LBD), multiple system atrophy (MSA), and AD cohorts were screened for the integration of pathogen genomes using the PathSeq computational tool.

RESULTS: Low PathSeq scores for human herpesvirus 6 (HHV-6) were consistent with the suspected integration of viral genome segments. The LBD and MSA cohorts had a significantly higher prevalence of this partial HHV-6 genome integration.

DISCUSSION: This higher prevalence in both synucleinopathies was not noted in other herpesviruses, suggesting that the integration of HHV-6 may play a role in a subset of these patients.

HIGHLIGHTS: Over 7500 whole-genome sequences from controls and dementia patients were analyzed. Sequences consistent with integrated herpesviruses were identified using PathSeq. Prevalence of partial HHV-6 integration was higher in synucleinopathies. Herpesviruses genome integration may play a role in subsets of dementia patients.},
}

Humans
*Dementia/virology/genetics
*Genome, Viral/genetics
*Herpesvirus 6, Human/genetics
*Virus Integration/genetics
Cohort Studies
Whole Genome Sequencing
Aged
Female
Male
*Herpesviridae/genetics
Alzheimer Disease/virology/genetics

@article {pmid41854033,
year = {2026},
author = {Fragkoudi, A and Stern, C and Pollock, D and Barker, TH and Semendric, I and Labra, J and Vucic, S and Whitehouse, J and Munn, Z},
title = {Identifying priorities for a national motor neurone disease (amyotrophic lateral sclerosis) guideline: results from an Australian online survey.},
journal = {Disability and rehabilitation},
volume = {},
number = {},
pages = {1-17},
doi = {10.1080/09638288.2026.2643544},
pmid = {41854033},
issn = {1464-5165},
abstract = {PURPOSE: To identify the priorities of people living with motor neurone disease (MND), their carers, asymptomatic genetic carriers, and healthcare professionals (HCPs) in Australia, to inform the development of a national MND care guideline.

METHODS: An anonymous online survey was distributed via MND organisations and groups to the Australian MND community.

RESULTS: Two hundred and fourteen individuals completed the survey. Of those, 44.8% (n = 96) were HCPs, with the remaining consisting of people living with MND, genetic carriers, and carers. The following areas were rated as extremely important and should be included in the guideline: diagnosis, service delivery models, clinical care management, caregiver support, and palliative care; while views on genetic testing and cognitive assessment were mixed. Participants highlighted a need for holistic care which considered emotional/psychological and physical aspects of MND. People with MND and their carers want the Australian MND care guideline to highlight proactive and coordinated support prioritising quality of life, while maintaining independence for as long as possible.

CONCLUSIONS: Identifying priorities is a fundamental step that will shape the forthcoming Australian MND care guideline. This methodology ensures the voices of those with lived experience and interest holders are incorporated from the outset.},
}

@article {pmid41854301,
year = {2026},
author = {Walker, TB and Trowbridge, JW and McMahon, S and Marzano, NR and Rice, L and Yerbury, JJ and Ecroyd, H and McAlary, L},
title = {Small heat shock proteins HspB1 and HspB5 differentially alter the condensation and aggregation of the TDP-43 low-complexity domain.},
journal = {Protein science : a publication of the Protein Society},
volume = {35},
number = {4},
pages = {e70539},
doi = {10.1002/pro.70539},
pmid = {41854301},
issn = {1469-896X},
support = {//Motor Neurone Disease Australia/ ; //FightMND/ ; APP1194872//National Health and Medical Research Council/ ; },
mesh = {Humans ; *DNA-Binding Proteins/chemistry/metabolism/genetics ; Protein Aggregates ; *HSP27 Heat-Shock Proteins/metabolism/chemistry/genetics ; *alpha-Crystallin B Chain/metabolism/chemistry/genetics ; Molecular Chaperones/metabolism ; Protein Domains ; Phosphorylation ; Heat-Shock Proteins ; },
abstract = {TAR DNA-binding protein 43 (TDP-43) is a nucleic acid-binding protein that regulates processes of mRNA metabolism, during which it undergoes condensation mediated by its C-terminal low-complexity domain (TDP-43[LCD]). TDP-43 aggregation and condensation are associated with neurodegenerative disease. However, the proteostasis mechanisms that regulate these processes remain elusive. Some evidence has shown that the molecular chaperone small heat shock protein HspB1 binds to and regulates the cytoplasmic phase separation of TDP-43, indicating that other small heat shock proteins may have similar effects. Here, we demonstrate divergent behaviors for HspB1 and its homolog HspB5 on TDP-43[LCD] condensation and aggregation. In addition to inhibiting TDP-43[LCD] aggregation, HspB1 partitions into TDP-43[LCD] condensates and increases the dynamic exchange of TDP-43[LCD] within condensates and with the surrounding solution. Phosphorylation-mimicking mutations within HspB1 enhance these effects. HspB5 inhibits TDP-43[LCD] aggregation more effectively than HspB1 and partitions into TDP-43[LCD] condensates, where it delays the pathological transition of the condensate to a gel/solid. We identify the N- and C-terminal regions of HspB1 and HspB5 to be crucial for the chaperone effects, and highlight the role of sequence diversity within these regions in defining small heat shock protein function. These findings demonstrate that HspB1 and HspB5 are regulators of TDP-43 phase separation and aggregation and may be potential therapeutic targets in mitigating toxic TDP-43 aggregation in neurodegenerative disease.},
}

Humans
*DNA-Binding Proteins/chemistry/metabolism/genetics
Protein Aggregates
*HSP27 Heat-Shock Proteins/metabolism/chemistry/genetics
*alpha-Crystallin B Chain/metabolism/chemistry/genetics
Molecular Chaperones/metabolism
Protein Domains
Phosphorylation
Heat-Shock Proteins

@article {pmid41854370,
year = {2026},
author = {Morojele, NK and London, L and Saban, A and Myers, B and Harker, N and Mokwena, K and Zingela, Z and Nkosi, S and Ayieko, P and Kapiga, S},
title = {Implications of COVID-19 Restrictions on the Ethics and Methods of a Multi-Site Study on Alcohol and Other Drug (AOD) Use Treatment among Men in South Africa.},
journal = {Journal of empirical research on human research ethics : JERHRE},
volume = {},
number = {},
pages = {15562646261427563},
doi = {10.1177/15562646261427563},
pmid = {41854370},
issn = {1556-2654},
abstract = {Public health measures for medical emergencies generate methodological and ethical challenges for human research. Using Emanuel et al.'s framework, we assessed the ethical integrity of the research methods used in a men's alcohol and other drug (AOD) use disorder study following their revision due to COVID-19 restrictions in South Africa. Following the amendments, the study's social value, favorable risk-benefit ratio, and respect for participants increased. Collaborative partnership, scientific validity, fair participant selection, independent review, and informed consent improved in terms of successful stakeholder engagements and interviewing procedures, but were compromised due to a cellphone access eligibility criterion and complicated consenting procedures. Methodological and ethical challenges of research during health emergencies can be navigated with flexibility and innovation.},
}

@article {pmid41854409,
year = {2026},
author = {Shukla, A and Upadhyay, A and Qadeer, M and Thakur, AD and Raj, R},
title = {Eco-friendly Immersion-Coating Strategy for Scalable and Durable Superhydrophobic Aluminum Surfaces.},
journal = {Langmuir : the ACS journal of surfaces and colloids},
volume = {},
number = {},
pages = {},
doi = {10.1021/acs.langmuir.5c05945},
pmid = {41854409},
issn = {1520-5827},
abstract = {Superhydrophobic (SHPB) surfaces have strong potential to mitigate corrosion, fouling, and icing, yet conventional fabrication methods rely on fluorinated modifiers, toxic reagents, or multistep protocols that limit scalability and conformal coverage on complex geometries. Here, we report an eco-friendly, scalable, and fluorine-free immersion-coating strategy for developing SHPB aluminum (SHPB-Al) surfaces using an ionic liquid (IL, 1-ethyl-3-methylimidazolium chloride) and lauric acid (LA) as nontoxic precursors. The central novelty lies in generating the requisite hierarchical roughness via an ionic liquid adsorption-driven surface modification mechanism, rather than through conventional material-removal or etching processes, thereby minimizing substrate damage and preserving structural integrity. Specifically, the two-step protocol first forms an IL-derived adsorbed substrate layer that induces hierarchical topography and hydrophilicity, followed by lauric acid functionalization to reduce surface energy and induce superhydrophobicity. Systematic optimization of the precursor concentration and dip duration identifies an optimum condition that achieves a static contact angle (SCA) of ≈165° with contact angle hysteresis (CAH) of <5°. Microscopy and surface analyses confirm the presence of hierarchical textures and robust chemical grafting. Durability tests under harsh chemical, thermal, mechanical, and environmental conditions reveal minimal performance loss (SCA > 150° and CAH < 10°), underscoring the coating's reliability. Droplet dynamics exhibit ≥15 successive rebounds, a coefficient of restitution of ≈0.9, and contact times as short as ≈10 ms, demonstrating ultralow adhesion. Building on these insights, we introduce an improvised one-step IL-LA codeposition method that simplifies the fabrication route while retaining high performance (SCA of ≈160° and CAH of ≈5°) and prolonged durability under environmental exposure. Together, this fluorine-free immersion-coating framework offers durable, scalable, and nontoxic routes for producing SHPB-Als, enabling conformal coatings on complex geometries such as heat-exchanger fins and paving the way for industrial deployment in harsh service environments.},
}

@article {pmid41854827,
year = {2026},
author = {Calvache Anaya, JA and Urdiales Merino, A and Druetta, NN and Sanz Rigo, M and Cardona Monjo, AM},
title = {Nonlinear and Asymmetric Refractive Sensitivity to Effective Lens Position Errors in Pseudophakic Eye Models.},
journal = {Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists)},
volume = {},
number = {},
pages = {},
pmid = {41854827},
issn = {1475-1313},
abstract = {PURPOSE: To perform a theoretical analysis of refractive sensitivity to effective lens position (ELP) errors in pseudophakic eyes using an explicit vergence-based optical model, and to quantify how this sensitivity depends on axial length (AL) and corneal power across a wide biometric range.

METHODS: A paraxial two-lens thin-lens model of the pseudophakic eye was developed, explicitly parameterised by AL, total corneal power (TCP), intraocular lens (IOL) power and effective lens position (ELP). Refraction was calculated at the corneal plane using vergence propagation. For a fixed reference ELP, the emmetropic IOL power was derived analytically for each combination of AL and TCP, and subsequently held constant while ELP was perturbed by ±1.0 mm. Simulations were performed for ALs from 19 to 31 mm and corneal powers from 38 to 50 dioptres. Refractive changes were approximated using families of quadratic regression models as functions of AL.

RESULTS: Refractive sensitivity to ELP errors was dominated by AL. Short eyes exhibited large refractive changes per millimetre of ELP error, whereas long eyes showed markedly reduced sensitivity. The relationship between refractive error and ELP displacement was nonlinear, resulting in asymmetric refractive effects for equal-magnitude anterior and posterior ELP deviations. TCP continuously modulated refractive sensitivity indirectly through its influence on the emmetropic IOL power required for a given optical configuration.

CONCLUSIONS: Refractive sensitivity to ELP errors in pseudophakic eye models is inherently nonlinear and asymmetric. This sensitivity is primarily governed by AL, with TCP acting as a secondary but systematic modulator through its effect on emmetropic IOL power. By explicitly separating optical sensitivity from ELP prediction, this vergence-based framework provides a physical basis for understanding ELP-related refractive variability across the biometric spectrum.},
}

@article {pmid41856038,
year = {2026},
author = {Nguyen, L},
title = {Repeat expansion RNA elicits toxicity through hybrid G-quadruplexes with promoter DNA.},
journal = {Neuron},
volume = {114},
number = {6},
pages = {969-971},
doi = {10.1016/j.neuron.2026.02.018},
pmid = {41856038},
issn = {1097-4199},
mesh = {*G-Quadruplexes ; Humans ; *Promoter Regions, Genetic/genetics ; C9orf72 Protein/genetics ; *Amyotrophic Lateral Sclerosis/genetics ; *DNA Repeat Expansion/genetics ; *RNA/genetics ; *DNA/genetics ; *Proteins/genetics ; },
abstract = {In this Neuron issue, Liu et al.[1] show that the C9orf72 expanded G4C2 repeat RNA forms hybrid G-quadruplexes with CG-rich promoter regions, which impedes RNA polymerase II. This process causes global transcriptional dysregulation in C9orf72 amyotrophic lateral sclerosis patient-derived cells.},
}

*G-Quadruplexes
Humans
*Promoter Regions, Genetic/genetics
C9orf72 Protein/genetics
*Amyotrophic Lateral Sclerosis/genetics
*DNA Repeat Expansion/genetics
*RNA/genetics
*DNA/genetics
*Proteins/genetics

@article {pmid41856386,
year = {2026},
author = {Sadler, SM and Volker, DK and Garguilo, D and Gould, D},
title = {An Analysis of United States Olympic and Paralympic Committee National Governing Body Policies Related to Body Pressures, Body Image Concerns, and Eating Pathology.},
journal = {Psychology of sport and exercise},
volume = {},
number = {},
pages = {103124},
doi = {10.1016/j.psychsport.2026.103124},
pmid = {41856386},
issn = {1878-5476},
abstract = {Athletes are often exposed to body pressures in sport environments, which can contribute to body image concerns and eating pathology, with lasting consequences for performance and well-being. Although research has highlighted the harmful impacts of these concerns, and has called for a broader investigation into the sources of athletes' experiences of these concerns, little is known about the role of sport organizations in influencing athletes' body pressures, body image concerns, and eating pathology. Using a descriptive qualitative research design within a post-positivist paradigmatic approach, the current study explored the frequency and content of body- and eating-related policies within the United States Olympic & Paralympic Committee's (USOPC) 51 national governing bodies, examining differences in policy frequency and content by sport type. National governing body websites were searched for policy documents aligned with Viollet et al.'s (2023) definition of sport policy. Following reflexive content analysis (Nicmanis, 2024) of 156 body- and eating-related policies, five overarching categories were identified: (a) uniform requirements, (b) athlete body image and nutrition-related supports, (c) organizational strategies to prevent body- and eating-related concerns, (d) body- and eating-related maltreatment, and (e) athletes' responsibilities related to nutrition and body weight. Findings highlight the inconsistent and often vague nature of existing national governing body policies, underscoring the need for standardized and comprehensive policies. Practical recommendations include developing both proactive and reactive body- and eating-related policies, providing clear and specific guidance, and critically examining gendered appearance standards communicated through policy to create a more inclusive sport culture that reduces athletes' experiences of body pressures, body image concerns, and eating pathology.},
}

@article {pmid41845095,
year = {2026},
author = {Gurunandan, K and Greve, A and Wilmot, E and Henson, RN},
title = {Does signed prediction error drive declarative memory? Evidence from variable choice paradigms.},
journal = {Memory & cognition},
volume = {},
number = {},
pages = {},
pmid = {41845095},
issn = {1532-5946},
support = {EP/Y016815/1//Engineering and Physical Sciences Research Council/ ; SUAG/046/G101400/MRC_/Medical Research Council/United Kingdom ; POS_2023_2_0034//Eusko Jaurlaritza/ ; },
abstract = {Prediction error (PE) is the discrepancy between predictions and new information. For a binary reward outcome, PE may be signed (positive if the outcome was better than predicted and negative if the outcome was worse than predicted) or unsigned (absolute value of "surprise"). Using a "variable choice" paradigm, De Loof et al. (PLOS ONE, 131, Article e0189212, 2018) examined the role of PE in one-shot learning of unknown translations of known words and showed that associative memory for the translation was greater when (financial) reward was more unexpected and lesser when an expected reward was not received (i.e., signed PE); an effect that they replicated in several subsequent studies. However, other work on PE in declarative memory has assumed that memory is greater when an outcome is more unexpected, without any explicit reward (i.e., unsigned PE). We replicated De Loof et al.'s paradigm with and without financial reward, and found that memory was explained slightly better by unsigned PE (Experiments 1A-1B). However, we also identified a potential confound in the paradigm that could explain the results without any role of PE, as confirmed by simulations. We therefore designed a modified version of the paradigm that circumvents this confound (Experiment 2). Results were inconsistent with the PE account. We conclude that variable choice paradigms may not be well-suited to investigate the role of PE in one-shot declarative learning, and that the purported role of signed PE in declarative memory requires further investigation.},
}

@article {pmid41845971,
year = {2026},
author = {Dahlhaus, R and Braun, RJ},
title = {The role of TDP-43 fragments in regular cellular functions and homeostatic failure.},
journal = {Neurobiology of disease},
volume = {},
number = {},
pages = {107349},
doi = {10.1016/j.nbd.2026.107349},
pmid = {41845971},
issn = {1095-953X},
abstract = {Amyotrophic lateral sclerosis (ALS) is characterized by the progressive degeneration of motor neurons, leading to severe muscle weakness, loss of voluntary movement, and respiratory failure. A widely noted feature of the disease is the presence of TDP-43 proteinopathies. Under homeostatic conditions, the RNA/DNA-binding protein TDP-43 mainly resides in the nucleus, where it functions to regulate gene expression, controlling not only RNA transcription and splicing, but also stability and transport to the cytoplasm. Upon the arrival at ribosomes, TDP-43 may further moderate translation, acting as a global repressor of protein synthesis. However, in over 95% of ALS cases, TDP-43 mislocalies from the nucleus to the cytoplasm, where it enriches in cytoplasmic inclusions that are marked by the presence of misfolded, ubiquitinated, phosphorylated and fragmented protein species of TDP-43. Although recent studies have tried to untangle the relationship between TDP fragments on the one hand, and cytotoxicity as well as neurodegeneration on the other, the results are still a matter of debate. Here, we review our current understanding of the different TDP fragments derived from proteolytic cleavage as well as alternative splicing, addressing the different N-terminal and C-terminal species and evaluating differences in rodent and primate models. We focus our analysis on the potential homeostatic functions of TDP fragments in the context of viral infections and myelination control, which are potentially pivotally interconnected. The findings illustrate several facets of fragmented TDP-43 protein species in scenarios of enhanced cellular stress. Gaining a detailed understanding could help to reveal new treatment options for ALS and other TDP-43 proteinopathies.},
}

@article {pmid41846014,
year = {2026},
author = {Yang, L and Fan, W and Wang, Z and Wu, M and Chen, Y and Cheng, J and Zhou, F and Guo, Z},
title = {The role of IRF5 in Microglia-Mediated neuroinflammation in ALS.},
journal = {Neuroscience letters},
volume = {},
number = {},
pages = {138580},
doi = {10.1016/j.neulet.2026.138580},
pmid = {41846014},
issn = {1872-7972},
abstract = {The occurrence and development of amyotrophic lateral sclerosis (ALS) involve neuroinflammatory responses, in which microglial activation plays a critical role. IRF5, a key regulator of inflammatory responses, is implicated in the disease mechanisms of various conditions. However, its mechanism in ALS remains unclear. This study found that IRF5 expression was significantly increased in hSOD1-G93A transgenic ALS mice and cell models, primarily localized in activated microglia. Silencing IRF5 altered microglial polarization, suppressed the release of inflammatory factors, enhanced phagocytic function, and reduced motor neuron apoptosis in a co-culture system. Mechanistic studies suggested that IRF5 may regulate microglial function through the NF-κB signaling pathway. This study reveals the key role of IRF5 in microglia-mediated neuroinflammation and neuronal damage in ALS, indicating that targeting IRF5 could represent a promising treatment strategy for this disease.},
}

@article {pmid41846418,
year = {2026},
author = {Ahire, C and Yadav, R and Bhamare, UU and Kaur, G and Palkar, MB},
title = {From Refractory Epilepsy to Neurodegeneration: Emerging Mechanistic and Clinical Insights Into the Ketogenic Diet.},
journal = {FASEB journal : official publication of the Federation of American Societies for Experimental Biology},
volume = {40},
number = {6},
pages = {e71609},
doi = {10.1096/fj.202503317R},
pmid = {41846418},
issn = {1530-6860},
mesh = {*Diet, Ketogenic/methods ; Humans ; Animals ; *Neurodegenerative Diseases/diet therapy/metabolism ; *Drug Resistant Epilepsy/diet therapy/metabolism ; },
abstract = {The ketogenic diet (KD), a high-fat, low-carbohydrate intervention, is well established for drug-resistant epilepsy and is increasingly explored in neurodegenerative disorders. KD reduces neuronal hyperexcitability through enhanced γ-aminobutyric acid (GABA)ergic transmission and modulation of neurotransmitter balance, underlying its efficacy in refractory epilepsy. Beyond seizure control, emerging evidence suggests KD may influence disease processes in conditions such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis, and Huntington's disease. Preclinical studies indicate that KD can modulate mitochondrial bioenergetics, oxidative stress, neuroinflammation, neurotransmitter signaling, and gut-brain interactions, though these effects are highly context-dependent and primarily derived from cellular and animal models. Clinical data remain limited, heterogeneous, and short-term, with small cohorts and variable outcome measures. Sustaining adherence and assessing long-term safety remain significant challenges in patient populations. This review summarizes recent experimental and clinical findings, highlighting the molecular and cellular mechanisms through which KD exerts neuroprotective effects. We also evaluate translational evidence and discuss the potential utility of KD as an adjunctive intervention in neurological disease management.},
}

*Diet, Ketogenic/methods
Humans
Animals
*Neurodegenerative Diseases/diet therapy/metabolism
*Drug Resistant Epilepsy/diet therapy/metabolism

@article {pmid41846510,
year = {2026},
author = {Raby, KL},
title = {Synthesizing five decades of research on sensitive caregiving: A commentary on Nivison et al. (2026).},
journal = {Journal of child psychology and psychiatry, and allied disciplines},
volume = {},
number = {},
pages = {},
doi = {10.1111/jcpp.70146},
pmid = {41846510},
issn = {1469-7610},
abstract = {This commentary highlights the contributions of Nivison et al.'s (2026) umbrella meta-analysis synthesizing five decades of research on sensitive caregiving and child development. Integrating findings from numerous meta-analyses, the authors demonstrate that caregiver sensitivity is meaningfully associated with multiple domains of child development. Notably, associations with cognitive and language development are at least as large as those with attachment security and behavior problems, expanding traditional conceptualizations of sensitivity's developmental significance. The findings further indicate substantial consistency across child, parent, and family demographic characteristics, while suggesting amplified benefits in socioeconomically disadvantaged contexts. This commentary underscores key gaps in the literature, including the need for meta-analytic investigations of children's peer competence, self-regulation, and physical health outcomes, as well as the need for refined measurement of caregiving dimensions. Although causal inferences require randomized intervention evidence, the synthesis provides compelling support for sensitive caregiving as a central determinant of healthy development and offers a roadmap for future research and policy.},
}

@article {pmid41846565,
year = {2026},
author = {Denby, K and Connelly, EDS and Glerup, H and Østgård, R and Egsgaard, AL and Vedsted, P and Appel, CW},
title = {Translation and cross-cultural adaptation of the Identification of Spondyloarthritis Questionnaire (IBIS-Q) into Danish for patients with inflammatory bowel disease.},
journal = {Scandinavian journal of gastroenterology},
volume = {},
number = {},
pages = {1-9},
doi = {10.1080/00365521.2026.2645081},
pmid = {41846565},
issn = {1502-7708},
abstract = {OBJECTIVES OF THE ARTICLE: Spondyloarthritis (SpA) affects 10-30% of patients with inflammatory bowel disease (IBD). An early diagnosis is essential as a delayed diagnosis of SpA increases the risk of disability and reduces quality of life. However, few screening tools for patients with IBD exist and none are available in Danish. To support early identification of spondyloarthritis symptoms in Danish patients with IBD, this study aimed to translate and cross-culturally adapt the Identification of Spondyloarthritis Questionnaire (IBIS-Q) into Danish and to assess face validity of the Danish version.

MATERIALS AND METHODS: Following Beaton et al.'s six step forward-backward translation guideline, the IBIS-Q was translated and cross-culturally adapted into Danish. This was done through an iterative process with an expert committee of translators, clinicians, methodologists and with inclusion of the IBIS-Q developers. Face validity was assessed through semi-structured interviews with 24 adults with and without arthritis-related symptoms.

RESULTS: Participants generally found the questionnaire easy to understand, and face validity was confirmed. The semantic equivalence of painful and sore in a Danish context was a central topic of discussion within the expert committee. However, only minor modifications were made, including the addition of an introductory paragraph and changing the questionnaire's title.

CONCLUSIONS: Following an international, standardised guideline, the IBIS-Q was successfully translated and cross-culturally adapted into Danish, and face validity was confirmed. The IBIS-Q is the first available questionnaire to assess Danish patients with IBD for SpA symptoms. Psychometric validation of the measurement properties of IBIS-Q is recommended prior to implementation.},
}

@article {pmid41847237,
year = {2026},
author = {Zarco-Martín, MT and Andreo-López, MC and Yagui-Beltrán, MS and Fernández-Soto, ML},
title = {Sarcopenia in amyotrophic lateral sclerosis: a key predictor of respiratory dysfunction and disease progression.},
journal = {Frontiers in nutrition},
volume = {13},
number = {},
pages = {1713253},
pmid = {41847237},
issn = {2296-861X},
abstract = {BACKGROUND: Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by progressive muscle weakness and respiratory decline. Sarcopenia remains underexplored in terms of prevalence and their relationship with disease progression. We aimed to determine the prevalence of sarcopenia in ALS patients, assess the predictive value of morphofunctional assessment tools for sarcopenia, and explore their relationship with respiratory function and disease progression.

METHODS: A cross-sectional study was conducted with 40 ALS patients at the ALS Multidisciplinary Unit, San Cecilio University Hospital in Granada. Sarcopenia was defined based on the European Working Group of Sarcopenia in Older People 2(EWGSOP2) and malnutrition was diagnosed using GLIM criteria. Morphofunctional status was assessed using: Phase Angle (PA) and body composition by Bioelectrical Impedance Vector Analysis, muscle strength through Handgrip Strength (HGS). Respiratory function was evaluated using Forced Vital Capacity (FVC). Associations between sarcopenia, body composition, respiratory function, and disease severity were analyzed using logistic regression models. Receiver operating characteristic analyses were performed to identify optimal predictive cut-off values.

RESULTS: Sarcopenia was identified in 25% of ALS patients. Compared with non-sarcopenic individuals, sarcopenic patients exhibited significantly lower muscle mass indices, PA, and HGS, along with higher extracellular water percentage (%ECW). Malnutrition was more frequent in sarcopenia group (90% vs. 25%, p < 0.001). Respiratory impairment was more pronounced in sarcopenic patients, with reduced FVC and elevated pCO₂ (p = 0.02), and a greater need for non-invasive mechanical ventilation (NIMV) (70% vs. 10%, p = 0.001). VC correlated positively with body cell mass index (BCMI) (r = 0.450), skeletal muscle mass index (SMI) (r = 0.413), and ALSFRS-R score (r = 0.731; all p < 0.05). Lower PA, BCMI, and ALSFRS-R scores, together with higher %ECW and partial pressure of carbon dioxide (pCO₂), predicted sarcopenia risk. Reduced BCMI, HGS, Short Physical Performance Battery (SPPB) and sarcopenia were associated with the need of NIMV. BCMI (cut-off:8.05 kg/m[2]; AUC:0.889) and ALSFRS-R (cut-off:33 points; AUC:0.884) were the most accurate predictors of sarcopenia and ventilatory support, respectively.

CONCLUSION: This study is the first to assess sarcopenia prevalence in ALS patients using standardized diagnostic criteria. The findings highlight the relationship between sarcopenia, malnutrition, and respiratory decline. PA, BCMI, and respiratory parameters emerge as potential tools for sarcopenia and NIMV risk stratification.},
}

@article {pmid41847382,
year = {2026},
author = {Talbot, SR and Scorrano, F and Gaburro, S and Lainee, P and van Gaalen, MM},
title = {From observation to optimization: behavioral metrics that matter in KPI based home cage monitoring.},
journal = {Frontiers in behavioral neuroscience},
volume = {20},
number = {},
pages = {1694689},
pmid = {41847382},
issn = {1662-5153},
abstract = {Most in vivo scientists would agree that digital biomarkers collected via home-cage monitoring generate valuable data. However, few can tell precisely how valuable. The gap between enthusiasm and evidence has slowed the adoption of digital biomarkers in preclinical research. This framework paper addresses that gap by providing explicit key performance indicators (KPIs), organized into scientific, operational, welfare, and financial categories. We show how return-on-investment calculations differ across pharmaceutical companies, contract research organizations (CROs), and academic institutions. Furthermore, we demonstrate the approach through a worked example in an Amyotrophic Lateral Sclerosis (ALS) mouse model that reduces full-time equivalent (FTE) requirements by half. When successfully integrated, digital biomarkers can generate richer datasets, reduce the number of animals, improve welfare, and enhance translational value. However, successful implementation requires clear performance metrics to justify investment and measure success. We also discuss what these technologies cannot do, because understanding limitations matters as much as understanding benefits.},
}

@article {pmid41850140,
year = {2026},
author = {Gao, Y and Sun, Z and Wei, Q and She, C and Wang, Y and Chen, J and Wang, M and Gui, X and Xia, X and Liu, Y and Wang, X},
title = {Employing an integrated computational simulation strategy to identify high-affinity ligands for TDP-43 amyloid proteins.},
journal = {Bioorganic & medicinal chemistry},
volume = {137},
number = {},
pages = {118634},
doi = {10.1016/j.bmc.2026.118634},
pmid = {41850140},
issn = {1464-3391},
abstract = {Developing high-affinity ligands targeting TDP-43 amyloid species is a potential therapeutic approach for amyotrophic lateral sclerosis (ALS). Here, we propose an integrated computational simulation strategy, which integrates multiple virtual screening methods, molecular dynamics simulations and binding free energy evaluations. Using this strategy, we successfully identified TDPL1, a high-affinity ligand for TDP-43 amyloid proteins. In vitro affinity assays confirmed the computational predictions. Based on the MD simulation results, we further investigated the binding mode between TDPL1 and TDP-43 amyloid proteins. Additionally, steered molecular dynamics simulations were employed to assess the impact of TDPL1 on the stability of β-sheet interactions within the TDP-43 amyloid structure. Our data demonstrate that TDPL1 not only binds effectively to TDP-43 amyloid proteins but also possesses the potential to disrupt the stability of amyloid aggregates. These findings provide a molecular foundation for the future development of diagnostic agents or targeted therapeutics for ALS and related diseases.},
}

@article {pmid41850233,
year = {2026},
author = {Guise, AJ and Ferber, KL and Young, D and Edwards, AL and Sabouri, S and Fraser, KB and Milliman, E and Plowey, ED and Zoghbi, J and Fradette, SM and Graham, DL},
title = {Identification of tofersen PD-response biomarkers in VALOR clinical trial CSF via multiplexed quantitative proteomics.},
journal = {Cell reports. Medicine},
volume = {7},
number = {3},
pages = {102648},
doi = {10.1016/j.xcrm.2026.102648},
pmid = {41850233},
issn = {2666-3791},
mesh = {Humans ; *Proteomics/methods ; *Biomarkers/cerebrospinal fluid ; *Amyotrophic Lateral Sclerosis/drug therapy/cerebrospinal fluid/genetics ; Superoxide Dismutase-1/genetics ; Male ; Female ; Middle Aged ; Adult ; Membrane Glycoproteins/cerebrospinal fluid ; Aged ; },
abstract = {Tofersen, the first approved genetically targeted therapy for amyotrophic lateral sclerosis (ALS), demonstrates significant lowering of plasma neurofilament in adults carrying mutations in the superoxide dismutase 1 (SOD1) gene; however, additional biomarkers of treatment response in ALS are lacking. Here, we analyze longitudinally collected cerebrospinal fluid (CSF) samples from the phase 3 VALOR clinical trial to identify candidate tofersen treatment-response biomarkers in SOD1-ALS via quantitative proteomics. We observe significant modulation from baseline abundance for 56 proteins in tofersen-treated participants relative to placebo, including CSF GPNMB, which is significantly and continuously elevated across all post-baseline timepoints. We orthogonally confirm this observation by GPNMB immunoassay in independent tofersen-treated cohorts. Taken together, these data identify pharmacodynamic-response biomarkers of tofersen treatment that can be measured as early as 4 weeks post-treatment in SOD1-ALS patients and demonstrate the utility of leveraging unbiased proteomic screening integrated with targeted validation methods to identify pharmacodynamic-response biomarkers in clinical trial patient samples.},
}

Humans
*Proteomics/methods
*Biomarkers/cerebrospinal fluid
*Amyotrophic Lateral Sclerosis/drug therapy/cerebrospinal fluid/genetics
Superoxide Dismutase-1/genetics
Male
Female
Middle Aged
Adult
Membrane Glycoproteins/cerebrospinal fluid
Aged

@article {pmid41850301,
year = {2026},
author = {Glaubitz, R and Harst, L and Ehm, F and Tesch, F and Barlinn, J and Krause, F and Schwarz, R and Malzahn, J and Werblow, A and Sinz, C and Randig, I and Riedel, T and Kutschker, C and Fiebig, S and Kubitza, J and Cording, M and Wolff, J and Schmitt, J},
title = {Testing a model-based approach for planning and regional coordination of hospital service group offerings: A model project in the East Saxony healthcare cluster.},
journal = {Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))},
volume = {},
number = {},
pages = {},
doi = {10.1055/a-2771-8616},
pmid = {41850301},
issn = {1439-4421},
abstract = {The hospital reform passed in 2024 will lead to regional and nationwide changes in the German hospital landscape. A joint project to examine the effects of the hospital reform on health care structures in the East Saxony region was initiated by the Center for Evidence-Based Health Care (ZEGV) at Dresden University Hospital, the regional health care coordinators of the four districts in the East Saxony care cluster and the city of Dresden, a statutory health insurance provider (AOK PLUS), and other regional stakeholders. In addition, the aim was to promote cooperation between the stakeholders for the purpose of future regionally coordinated planning for inpatient care. The project involved the application and validation of a model displaying a hospital's relevance for stationary care provision (care relevance model), which was developed in cooperation with the GKV-Spitzenverband (National Association of Statutory Health Insurance Funds) and is based on the performance data of German hospitals in accordance with § 21 KHEntgG (Hospital Remuneration Act). Thirty of the 36 hospital locations in the project region agreed to participate in the project. Both in a questionnaire-based self-assessment provided by the clinics and during a joint cluster conference, the tension between the need for cooperation and individual interests became clear. At this point, the care relevance model developed can scientifically support the dialogue between the stakeholders and thus support inpatient planning.Im Zuge der im Jahr 2024 verabschiedeten Krankenhausreform wird es zu regionalen und deutschlandweiten Veränderungen der Krankenhauslandschaft kommen. Vor diesem Hintergrund wurde ein gemeinsames Projekt des Zentrums für Evidenzbasierte Gesundheitsversorgung (ZEGV) der Hochschulmedizin Dresden mit den Regionalkoordinator:innen für Gesundheit der vier Landkreise im Versorgungscluster Ostsachsen und der Stadt Dresden, der AOK PLUS und weiteren regionalen Akteuren initiiert, um die Auswirkungen der Krankenhausreform auf die Versorgungsstrukturen in der Region Ostsachsen zu untersuchen. Zudem sollte die Kooperation zwischen den Akteuren zum Zweck einer zukünftigen regional abgestimmten Planung für die stationäre Versorgung gefördert werden. Im Projekt erfolgte die Anwendung und Validierung eines Versorgungsrelevanzmodells, welches in Kooperation mit dem GKV-Spitzenverband entwickelt wurde und auf den Leistungsdaten deutscher Krankenhäuser nach § 21 KHEntgG basiert. Dreißig von 36 Krankenhausstandorten in der Projektregion konnten für eine Teilnahme am Projekt gewonnen werden. Sowohl in einer fragebogengestützten Selbstauskunft der Kliniken als auch im Rahmen der zusammenführenden Clusterkonferenz wurde das Spannungsfeld zwischen Kooperationsnotwendigkeiten und Partikularinteressen deutlich. An dieser Stelle kann das entwickelte Versorgungsrelevanzmodell den Dialog zwischen den Akteuren wissenschaftlich begleiten und so die stationäre Planung unterstützen.},
}

@article {pmid41850981,
year = {2026},
author = {Pu, Y and Cao, X},
title = {KLHL6: a proteostatic guardian against T-cell exhaustion.},
journal = {Trends in immunology},
volume = {},
number = {},
pages = {},
doi = {10.1016/j.it.2026.02.003},
pmid = {41850981},
issn = {1471-4981},
abstract = {Cheng et al.'s recent study identifies the Cullin3-RING E3 ubiquitin ligase complexes (CRL3) adaptor protein Kelch-like protein 6 (KLHL6) as a proteostasis regulator whose downregulation in chronically stimulated T cells leads to the accumulation of thymocyte selection-associated high mobility group box protein and phosphoglycerate mutase family member 5, driving T-cell dysfunction. This work positions T-cell exhaustion as a proteostatic disorder and highlights KLHL6 as a promising target for cancer immunotherapy.},
}

@article {pmid41842529,
year = {2026},
author = {Zhao, J and Ji, X and Leng, L and Wang, M and Li, Y and Wang, W and Sun, Y},
title = {Integrating terrain and spectral attributes for automated water-land classification using airborne LiDAR without any prior information.},
journal = {Applied optics},
volume = {65},
number = {7},
pages = {2053-2062},
doi = {10.1364/AO.579495},
pmid = {41842529},
issn = {1539-4522},
abstract = {Accurate differentiation between water and land is crucial for flood monitoring, land-use planning, and ecological protection. Airborne laser scanning (ALS) provides high-resolution three-dimensional topographic and intensity data, offering a robust foundation for these applications. However, existing classification approaches largely depend on manually defined thresholds or supervised learning, with limited attention to the underlying synergies among multidimensional features, thereby constraining both accuracy and automation. To address these limitations, this study introduces an unsupervised classification framework based on multi-feature fusion, where four fusion indicators are derived from 14 geometric and radiometric features, enabling fully automated water-land classification. Experiments on two ALS datasets from central Dublin demonstrate that the proposed method substantially outperforms SLIER, fuzzy logic, and elevation-threshold approaches, achieving overall accuracies of 98.3% and 97.3%, with Kappa coefficients of 0.903 and 0.914. Beyond improving classification accuracy and reducing computational complexity, the fusion indicators also enhance digital elevation model (DEM) reconstruction by repairing voids in water regions and refining boundary delineation, thereby reinforcing the value of ALS data for environmental monitoring and disaster management.},
}

@article {pmid41843813,
year = {2026},
author = {Meyer, T and Ticozzi, N and Weber, M and Ravits, J and Lingor, P and Kuźma-Kozakiewicz, M and Boentert, M and Grehl, T and Corcia, P and Povedano Panadés, M and Maier, A and Ingre, C and Cetin, H and Weydt, P and Lunetta, C and van den Berg, L and Ludolph, AC and Brenner, D and Turner, MR and Genge, A},
title = {ALS motor phenotypes: a revised 'OPM' classification.},
journal = {Amyotrophic lateral sclerosis & frontotemporal degeneration},
volume = {},
number = {},
pages = {1-13},
doi = {10.1080/21678421.2026.2644277},
pmid = {41843813},
issn = {2167-9223},
abstract = {BACKGROUND: Defining motor phenotypes in amyotrophic lateral sclerosis (ALS) is important for individualized care and optimal therapeutic trial design. The "ALS-OPM" classification is based on the onset region (O), the propagation of motor symptoms (P), and the degree of clinical upper (UMN) and/or lower (LMN) motor neuron dysfunction (M).

METHODS: An international ALS expert focus group was held in September 2025, followed by a consensus process through which revisions of the OPM classification were finalized.

RESULTS: Onset (O1-4) identifies first motor symptoms as relating to the head (O1), distal/proximal arm (O2d/p), respiratory/axial trunk (O3r/a), or distal/proximal leg (O4d/p). Onset symptoms are defined by weakness or slowed, poorly coordinated voluntary movements in the muscles of the head, arm, trunk, or leg, including dysarthria, dysphagia, dysphonia, dyspnea, and axial instability. Propagation (P1(n)) or absence of propagation (P0(n)) of motor symptoms from the onset region to another body region are designated, where n denotes the number of months from onset to propagation or assessment. The degree of UMN dysfunction (slowed, poorly coordinated voluntary movements, hyperreflexia and/or spastic muscle tone, emotional lability) and/or LMN dysfunction (weakness with associated muscle atrophy) is classified as follows: balanced UMN and LMN dysfunction (M0); dominant (M1d) or pure UMN dysfunction (M1p); dominant (M2d) or pure LMN dysfunction (M2p); and dissociated UMN/LMN dysfunction (M3), in which the arms and legs predominantly show LMN and UMN involvement, respectively.

CONCLUSION: The revised ALS-OPM classification aims to make it routine, practical and feasible to capture phenotype in clinical practice and therapeutic trials.},
}

@article {pmid41350059,
year = {2026},
author = {Sarker, SC and Chen, J and Wang, C and He, S and Yu, H and Li, X and Cui, H},
title = {ALS target-site mutations and overexpression synergistically enhance mesosulfuron resistance in Lolium perenne.},
journal = {Pesticide biochemistry and physiology},
volume = {216},
number = {Pt 2},
pages = {106802},
doi = {10.1016/j.pestbp.2025.106802},
pmid = {41350059},
issn = {1095-9939},
mesh = {*Acetolactate Synthase/genetics/metabolism ; *Lolium/genetics/drug effects/enzymology ; *Herbicide Resistance/genetics ; *Sulfonylurea Compounds/pharmacology ; Mutation ; *Herbicides/pharmacology ; *Plant Proteins/genetics/metabolism ; },
abstract = {The invasive weed Lolium perenne (perennial ryegrass) poses a considerable threat to winter wheat crops in China and is hardly controlled by acetolactate synthase (ALS) inhibitors after years of application. In this study, four L. perenne populations from different locations in Henan were collected to evaluate the mechanisms of target site resistance to mesosulfuron-methyl. The resistant index (RI) of these four populations ranged from 122.73 to 149.26 compared to the susceptible population. ALS gene sequencing revealed three specific target site mutations: Pro-197-Thr, Asp-376-Glu, and Trp-574-Leu. Among these, Trp-574-Leu has not been previously reported in L. perenne. Three simultaneous double mutations were found in the same individual: Pro-197-Thr and Asp-376-Glu (Group I); Pro-197-Thr and Trp-574-Leu (Group II); and Asp-376-Glu and Trp-574-Leu (Group III). The gene expression levels of the double mutant groups were significantly higher than those of the susceptible plants. The I50 values obtained from the ALS enzyme assays showed that all three double mutant groups demonstrated a 136.75 to 149-fold increase compared to the enzyme activity of susceptible plants. Molecular docking analysis of mutant ALS proteins with mesosulfuron-methyl indicated that the mutant proteins had a reduced binding affinity to the herbicide. This reduced affinity was due to the disruption of hydrogen bonds and other key interactions, which contributed to increased herbicide resistance. Double target site mutations in a single ALS gene are a crucial mechanism for conferring high levels of mesosulfuron-methyl resistance in L. perenne.},
}

*Acetolactate Synthase/genetics/metabolism
*Lolium/genetics/drug effects/enzymology
*Herbicide Resistance/genetics
*Sulfonylurea Compounds/pharmacology
Mutation
*Herbicides/pharmacology
*Plant Proteins/genetics/metabolism

@article {pmid41350075,
year = {2026},
author = {Wu, G and Chen, Y and Yao, Y and Huang, W and Wu, K},
title = {Integrating network toxicology and molecular docking to uncover mechanisms of novel herbicide-induced neurodegeneration.},
journal = {Pesticide biochemistry and physiology},
volume = {216},
number = {Pt 2},
pages = {106821},
doi = {10.1016/j.pestbp.2025.106821},
pmid = {41350075},
issn = {1095-9939},
mesh = {*Herbicides/toxicity/chemistry ; *Molecular Docking Simulation ; Humans ; *Neurodegenerative Diseases/chemically induced/metabolism ; Protein Interaction Maps ; },
abstract = {Rising global reliance on novel herbicides has outpaced understanding of their potential neurotoxicity. This study employs an integrative network-toxicology pipeline to clarify how five widely used compounds, including mesotrione, topramezone, flufenazopyr, glufosinate-ammonium and beflubutamid-M, may contribute to Alzheimer's, Parkinson's, Huntington's, and amyotrophic lateral sclerosis pathogenesis. We first predicted toxic liabilities in eMolTox, SwissADME and ProTox, then harvested 310 human targets via PubChem, ChEMBL, STITCH and Swiss Target Prediction. Intersection with 3668-3429 disease genes (GeneCards/ OMIM) revealed 91-176 shared targets per disorder. PPI networks constructed in STRING and refined with Cytoscape (MCODE, cytoHubba) and novel NodeIdentifyR algorithm converged on eleven high-impact hub genes: EGFR, GSK3B, SRC, AKT1, MAPT, CASP3, MMP9, MTOR, PTK2, BCL2L1 and MAPK8. GO and KEGG enrichment analyses highlighted apoptosis, PI3K-Akt and MAPK signaling dysregulation. Single-cell and bulk transcriptomic atlases confirmed aberrant expression of these hubs in patient brains; Molecular docking demonstrated low-nanomolar affinities of all herbicides for multiple hub proteins, with mesotrione and topramezone displaying the broadest binding spectra and SRC emerging as a common high-affinity site. Molecular dynamics simulations supported stable binding in a representative herbicide-protein complex. Additionally, in vivo and in vitro experiments using Glufosinate-ammonium exposure corroborated the computational findings, underscoring the robustness of our approach. Together, these results establish a systems-level framework linking environmental herbicide exposure to neurodegeneration and nominate tractable targets for surveillance and therapeutic intervention.},
}

*Herbicides/toxicity/chemistry
*Molecular Docking Simulation
Humans
*Neurodegenerative Diseases/chemically induced/metabolism
Protein Interaction Maps

@article {pmid41350201,
year = {2026},
author = {Hokkoku, K and Inoue, M and Yamada, S and Namba, H and Matsukura, K and Mukai, T and Chiba, T and Hatanaka, Y and Kobayashi, S and Sonoo, M},
title = {Reply to the letter by Marimbun et al. on fasciculation awareness in ALS.},
journal = {Journal of the neurological sciences},
volume = {480},
number = {},
pages = {125677},
doi = {10.1016/j.jns.2025.125677},
pmid = {41350201},
issn = {1878-5883},
}

@article {pmid41350294,
year = {2025},
author = {Williams, SE and Luisi, K and Liang, C and Cane, A and Begier, E},
title = {Methodological Issues in Taquet et al.'s analysis preclude any conclusions regarding AS01 adjuvant's specific role in dementia prevention.},
journal = {NPJ vaccines},
volume = {10},
number = {1},
pages = {255},
pmid = {41350294},
issn = {2059-0105},
abstract = {Taquet et al. evaluated the impact of AS01-adjuvanted vaccines on subsequent dementia diagnosis[1]. The authors conclude: "No difference was observed between the two AS01-adjuvanted vaccines, suggesting that the AS01 adjuvant itself plays a direct role in lowering dementia risk". Although the study offers promising evidence, the inference regarding the role of AS01 adjuvant in dementia prevention is not convincingly supported by the presented data or other published literature[2].},
}

@article {pmid41350409,
year = {2025},
author = {Cheng, S and Zhong, C and Zhu, H and Mu, K and Jiang, H and Zhong, P and Ma, Z and Liu, X and Wang, Z and Liu, R and Ding, Y},
title = {Structural mechanisms and insights on multiple nanobodies binding diverse SOD1 epitopes.},
journal = {Communications biology},
volume = {9},
number = {1},
pages = {30},
pmid = {41350409},
issn = {2399-3642},
mesh = {*Superoxide Dismutase-1/chemistry/metabolism/immunology/genetics ; *Single-Domain Antibodies/chemistry/metabolism/immunology ; Humans ; *Epitopes/chemistry/immunology/metabolism ; Protein Binding ; Amyotrophic Lateral Sclerosis ; Models, Molecular ; Crystallography, X-Ray ; Protein Conformation ; },
abstract = {Copper/zinc superoxide dismutase (SOD1) is a crucial metalloenzyme that mitigates oxidative stress by scavenging superoxide anion radicals. Mutations and aggregation of SOD1 are closely linked to the pathogenesis of amyotrophic lateral sclerosis (ALS). Targeting pathogenic SOD1 with nanobodies presents a promising therapeutic approach. We report the first high-resolution crystal structures of SOD1 in complex with three distinct nanobodies (Nb1, Nb2, and Nb3) and their multimeric assemblies (1:2 and 1:3 stoichiometries), revealing distinct binding epitopes primarily mediated by their complementarity determining regions (CDRs) through hydrogen bonds, salt bridges, and hydrophobic interactions. Structural and biophysical analyses using isothermal titration calorimetry (ITC) and fluorescence-detection size-exclusion chromatography (FSEC) demonstrated that all three nanobodies bind SOD1 simultaneously with nanomolar affinities (KD values ranging from 23.2 nM to 529 nM). Notably, engineered multimeric tandem nanobodies (Nb1-Nb2-Nb3) achieved higher affinity (KD = 4.39 nM) compared to single nanobodies, as validated by ITC. Characterization via dynamic light scattering (DLS) further revealed colloidal stability of SOD1-nanobody complexes. These results provide the first atomic-resolution insights into multi-nanobody targeting of SOD1 without steric interference, establishing a foundation for developing high-affinity tools to detect and manipulate SOD1 in ALS and related neurodegenerative diseases.},
}

*Superoxide Dismutase-1/chemistry/metabolism/immunology/genetics
*Single-Domain Antibodies/chemistry/metabolism/immunology
Humans
*Epitopes/chemistry/immunology/metabolism
Protein Binding
Amyotrophic Lateral Sclerosis
Models, Molecular
Crystallography, X-Ray
Protein Conformation

@article {pmid41350806,
year = {2025},
author = {Nakamura, R and Tohnai, G and Atsuta, N and Matsuda, Y and Morimoto, S and Ito, D and Katsuno, M and Izumi, Y and Morita, M and Iwata, I and Yabe, I and Nakazato, T and Hattori, N and Hirayama, T and Kano, O and Tamura, A and Suzuki, N and Aoki, M and Shibuya, K and Kuwabara, S and Oda, M and Hashimoto, R and Aiba, I and Ishihara, T and Onodera, O and Yamashita, T and Ishiura, H and Bokuda, K and Shimizu, T and Ikeda, Y and Hasegawa, K and Tanaka, F and Yokota, T and Kanai, K and Noto, YI and Kaji, R and Watanabe, H and Konishi, T and Hasegawa, M and Fukaya, H and Niwa, JI and Doyu, M and Okada, Y and Nakamura, S and Ozawa, F and Okano, H and Nakatochi, M and Sobue, G and , },
title = {A genome-wide association study identifies the GPM6A locus associated with age at onset in ALS.},
journal = {Communications biology},
volume = {8},
number = {1},
pages = {1720},
pmid = {41350806},
issn = {2399-3642},
support = {23FC0201//Ministry of Health, Labour and Welfare (Ministry of Health, Labour and Welfare, Japan)/ ; JP23ek0109492, JP23ak0101111, JP23ak0101124, JP24wm0425009//Japan Agency for Medical Research and Development (AMED)/ ; JP24ak0101216, JP24ak0101222, JP25wn0625519, JP25ak0101216, JP25ak0101222, JP25ek0109617//Japan Agency for Medical Research and Development (AMED)/ ; JP23ek0109538//Japan Agency for Medical Research and Development (AMED)/ ; JP23bm1123046, JP23kk0305024, JP23bm1423002//Japan Agency for Medical Research and Development (AMED)/ ; JP24bm1423003//Japan Agency for Medical Research and Development (AMED)/ ; JP23bm1123046, JP23kk0305024, JP23bm1423002//Japan Agency for Medical Research and Development (AMED)/ ; JP19km0405216//Japan Agency for Medical Research and Development (AMED)/ ; 19K07973//MEXT | Japan Society for the Promotion of Science (JSPS)/ ; 22K07359//MEXT | Japan Society for the Promotion of Science (JSPS)/ ; 22K07509//MEXT | Japan Society for the Promotion of Science (JSPS)/ ; 19K06523//MEXT | Japan Society for the Promotion of Science (JSPS)/ ; 22K07359//MEXT | Japan Society for the Promotion of Science (JSPS)/ ; 19K07973//MEXT | Japan Society for the Promotion of Science (JSPS)/ ; 22K07509//MEXT | Japan Society for the Promotion of Science (JSPS)/ ; 23K06835//MEXT | Japan Society for the Promotion of Science (JSPS)/ ; 22K07359//MEXT | Japan Society for the Promotion of Science (JSPS)/ ; 22K07509//MEXT | Japan Society for the Promotion of Science (JSPS)/ ; 25K10781//MEXT | Japan Society for the Promotion of Science (JSPS)/ ; 21H05278//MEXT | Japan Society for the Promotion of Science (JSPS)/ ; 19K06523//MEXT | Japan Society for the Promotion of Science (JSPS)/ ; 23K06975//MEXT | Japan Society for the Promotion of Science (JSPS)/ ; 22H02988//MEXT | Japan Society for the Promotion of Science (JSPS)/ ; 23K06975//MEXT | Japan Society for the Promotion of Science (JSPS)/ ; 23K24249//MEXT | Japan Society for the Promotion of Science (JSPS)/ ; 21H05278//MEXT | Japan Society for the Promotion of Science (JSPS)/ ; 16H06277//MEXT | Japan Society for the Promotion of Science (JSPS)/ ; 22H04923//MEXT | Japan Society for the Promotion of Science (JSPS)/ ; 22H03350//MEXT | Japan Society for the Promotion of Science (JSPS)/ ; },
mesh = {Humans ; *Amyotrophic Lateral Sclerosis/genetics/epidemiology ; *Genome-Wide Association Study ; Age of Onset ; Female ; Male ; Middle Aged ; Polymorphism, Single Nucleotide ; Aged ; Genetic Predisposition to Disease ; Adult ; *GPI-Linked Proteins/genetics ; Japan ; },
abstract = {Amyotrophic lateral sclerosis (ALS) exhibits considerable clinical variability, such as differences in age at onset (AAO). Multiple factors, including genetic factors, may underlie this variability; however, the specific determinants remain unclear. To identify genes affecting AAO, we have conducted a genome-wide association study in Japanese patients with ALS (discovery cohort: n = 1808; replication cohort: n = 207). Here, we show that the minor A allele of rs113161727 at the ADAM29-GPM6A locus is associated with a younger AAO in the discovery cohort (effect, -4.27 years; p = 4.60 × 10[-8]); this finding has been confirmed in the replication cohort (p = 0.0068) and meta-analysis (p = 1.08 × 10[-9]). Among 65 ALS patients with a SOD1 mutation, the AAO has been found to be 10.2 years younger in those with the A allele than in those without it (p = 0.002). This variant correlates with GPM6A upregulation in iPSC-derived motor neurons, suggesting GPM6A as a candidate AAO modifier. Overall, our study highlights the impact of genetic modifiers on ALS heterogeneity and provides a potential target for delaying disease onset.},
}

Humans
*Amyotrophic Lateral Sclerosis/genetics/epidemiology
*Genome-Wide Association Study
Age of Onset
Female
Male
Middle Aged
Polymorphism, Single Nucleotide
Aged
Genetic Predisposition to Disease
Adult
*GPI-Linked Proteins/genetics
Japan

@article {pmid41351663,
year = {2025},
author = {Amirian, R and Merati, A and Babamohamadi, M and Mirahmadi, Y and Esfahani, ML and Rahmani, S and Izadi, Z and Rezazadeh, D},
title = {Navigating the Autophagy Maze: ATG and Their Impact on Neurodegenerative Diseases.},
journal = {Molecular neurobiology},
volume = {63},
number = {1},
pages = {260},
pmid = {41351663},
issn = {1559-1182},
mesh = {*Autophagy/genetics/physiology ; Humans ; *Neurodegenerative Diseases/genetics/metabolism/pathology ; Animals ; *Autophagy-Related Proteins/metabolism/genetics ; Signal Transduction ; },
abstract = {Autophagy, a tightly regulated process essential for maintaining cellular homeostasis, plays a critical role in the pathogenesis and progression of neurodegenerative diseases (NDs). These disorders-marked by diverse mechanisms and clinical heterogeneity-pose significant challenges in developing effective therapies. Central to the autophagic machinery are autophagy-related genes (ATGs), whose functions and variants are increasingly recognized as pivotal in modulating disease-specific pathways. This review explores the intricate roles of ATGs in NDs, emphasizing the need for a comprehensive understanding of molecular signaling networks, protein-protein interactions, and regulatory checkpoints that may serve as therapeutic targets. We highlight recent advancements in disease modeling, autophagy assays, and biomarker identification that facilitate the translation of ATG-related discoveries into clinical practice. Furthermore, we underscore the importance of interdisciplinary collaboration across academia, industry, clinical medicine, and regulatory bodies to harness the therapeutic potential of autophagy. This article aims to serve as a detailed roadmap for understanding the role of ATGs in NDs and to illuminate promising avenues for future research and therapeutic development.},
}

*Autophagy/genetics/physiology
Humans
*Neurodegenerative Diseases/genetics/metabolism/pathology
Animals
*Autophagy-Related Proteins/metabolism/genetics
Signal Transduction

@article {pmid41352634,
year = {2026},
author = {Geleta, LA and Doyle, C and Garton, FC and Fowler, M and Carr, JM and Akkari, PA and McRae, AF and Rogers, ML and Madakkatel, I and Benyamin, B},
title = {The roles of human endogenous retrovirus in neurodegenerative diseases: A systematic review.},
journal = {Brain, behavior, and immunity},
volume = {132},
number = {},
pages = {106201},
doi = {10.1016/j.bbi.2025.106201},
pmid = {41352634},
issn = {1090-2139},
mesh = {Humans ; *Endogenous Retroviruses/genetics/physiology ; *Neurodegenerative Diseases/virology/genetics ; Alzheimer Disease/virology ; Amyotrophic Lateral Sclerosis/virology ; Parkinson Disease/virology ; Frontotemporal Dementia/virology ; },
abstract = {BACKGROUND: Human endogenous retroviruses (HERVs) constitute ∼8 % of the human genome, far exceeding the 2 % occupied by protein-coding genes. Although most HERV sequences are inactive, some HERV elements can be reactivated under certain conditions and may contribute to neurodegenerative diseases (NDDs). However, the findings vary across different HERV families, disease models, and detection methods. Here, we systematically review and synthesize the available evidence on the role of HERVs in human NDDs and reconcile inconsistencies in the literature.

METHODS: We systematically searched MEDLINE, EMBASE, Cochrane Library, PsycINFO, Scopus, Web of Science, CINAHL, and Emcare to identify relevant studies. Two independent reviewers screened studies, assessed quality, and extracted data. Qualitative synthesis was conducted for all included NDDs, specifically Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and Parkinson's disease (PD), and due to data availability, meta-analysis was used to assess the impact of HERVs antibodies on ALS only.

RESULTS: Twenty-six studies (N ranges: 6-485) met the inclusion criteria, with majority focusing on HERV-K and ALS. Across studies, the association between HERV expression and NDDs was inconsistent, particularly for ALS, PD, and FTD, whereas investigations in AD showed a more consistent upregulation of specific HERVs. Studies relying on polymerase chain reaction (PCR) (typically smaller) showed inconsistent associations (21 studies), while RNA sequencing studies reported consistent associations (9 studies). A preliminary meta-analysis revealed a fivefold increase [OR: 5.83; 95 % CI: 4.14, 8.18] in ALS risk among participants with positive HERV antibodies.

CONCLUSIONS: The inconsistencies in HERV involvement across NDDs highlight the need for further studies employing standardized methodologies. RNAseq findings on the association of HERVs expression and NDDs support the need for large-scale RNA sequencing studies (rather than small, PCR studies) and careful tissue selection to clarify HERVs' role in NDDs. The association of HERV-K antibodies with ALS risk and prognosis suggests a significant role in disease, which could help detect biomarkers and used as a target for treatment.},
}

Humans
*Endogenous Retroviruses/genetics/physiology
*Neurodegenerative Diseases/virology/genetics
Alzheimer Disease/virology
Amyotrophic Lateral Sclerosis/virology
Parkinson Disease/virology
Frontotemporal Dementia/virology

@article {pmid41352688,
year = {2026},
author = {Chikuchi, R and Kato, Y and Tomatsu, A and Nishisaki, S and Kawakami, Y and Yoshimura, T and Li, J and Iguchi, Y and Onodera, K and Hashimoto, R and Aiba, I and Nakamura, R and Tohnai, G and Atsuta, N and Sobue, G and Okada, Y and Katsuno, M and Yokoi, S},
title = {The TDP-43[I383V] heterozygous mutation results in increased TDP-43 expression and altered neuronal activity in ALS patient-derived iPSC motor neurons.},
journal = {Neuroscience research},
volume = {222},
number = {},
pages = {105003},
doi = {10.1016/j.neures.2025.105003},
pmid = {41352688},
issn = {1872-8111},
mesh = {*Amyotrophic Lateral Sclerosis/genetics/metabolism/pathology ; *Motor Neurons/metabolism ; *Induced Pluripotent Stem Cells/metabolism ; Humans ; *DNA-Binding Proteins/genetics/metabolism ; Animals ; Mutation/genetics ; Rats ; Heterozygote ; Coculture Techniques ; Cells, Cultured ; },
abstract = {TAR-binding protein 43 (TDP-43) is a pathogenic RNA-binding protein associated with amyotrophic lateral sclerosis (ALS). To elucidate the pathogenesis of ALS, we generated induced pluripotent stem cells (iPSCs) from lymphoblastoid cell line (LCL) cells of an ALS patient with the TDP-43[I383V] heterozygous mutation. Furthermore, we generated isogenic wild-type iPSCs from wild-type LCL cells using scarless genome editing with CRISPR/Cas9. A modified iPSC-derived motor neuron culture method utilizing BrainPhys neuronal medium and rat astrocyte co-culture effectively promoted and maintained neuronal activity. Under these conditions, the TDP-43[I383V] heterozygous mutation resulted in increased TDP-43 protein expression through prolonged stabilization. Moreover, mutant iPSC-derived motor neurons showed increased numbers of pre-synapses and altered neuronal activity. These results suggest that the modified motor neuron culture method can help elucidate abnormalities in TDP-43 expression, synapse formation, and neuronal activity caused by the heterozygous TDP-43[I383V] mutation. The model developed in this study has the potential to facilitate the analysis of the early pathological phenotype of ALS.},
}

*Amyotrophic Lateral Sclerosis/genetics/metabolism/pathology
*Motor Neurons/metabolism
*Induced Pluripotent Stem Cells/metabolism
Humans
*DNA-Binding Proteins/genetics/metabolism
Animals
Mutation/genetics
Rats
Heterozygote
Coculture Techniques
Cells, Cultured

@article {pmid41352714,
year = {2025},
author = {Maas, D and Spindler, A and Zappi, I and Shapiro, J and Lo Sicco, KI},
title = {Response to Vaz de Faria et al's ''Forehead atrophy in frontal fibrosing alopecia: An ultrasonographic and histopathological study of 10 patients".},
journal = {Journal of the American Academy of Dermatology},
volume = {},
number = {},
pages = {},
doi = {10.1016/j.jaad.2025.10.159},
pmid = {41352714},
issn = {1097-6787},
}

@article {pmid41352717,
year = {2025},
author = {Doche, I and Vaz de Faria, JR},
title = {Response to Maas et al, "Response to Vaz de Faria et al's "Forehead atrophy in frontal fibrosing alopecia: An ultrasonographic and histopathological study of 10 patients"".},
journal = {Journal of the American Academy of Dermatology},
volume = {},
number = {},
pages = {},
doi = {10.1016/j.jaad.2025.12.015},
pmid = {41352717},
issn = {1097-6787},
}

@article {pmid41352930,
year = {2026},
author = {Queral-Beltran, A and Lacorte, S and Tauler, R},
title = {GC-orbitrap-HRMS with ROIMCR and MSident targeted and non-targeted analysis of persistent organic pollutants in fish-based certified reference materials.},
journal = {Analytica chimica acta},
volume = {1383},
number = {},
pages = {344892},
doi = {10.1016/j.aca.2025.344892},
pmid = {41352930},
issn = {1873-4324},
mesh = {Animals ; *Gas Chromatography-Mass Spectrometry/standards/methods ; *Fishes ; *Persistent Organic Pollutants ; Reference Standards ; },
abstract = {The use of fish-based reference materials allows the validation of analytical methods used for the monitoring of persistent organic pollutants (POPs) in environmental samples. Thus, the aim of this work has been to apply and validate the Regions of Interest Multivariate Curve Resolution (ROIMCR) procedure, in a first instance, to quantify POPs using two fish-based certified reference materials (CRM) provided by the Institute of Reference Materials (IRMM); and also to identify, with the MSident program, the presence of more POPs in the same samples. Samples were extracted and analyzed by gas chromatography coupled to an Orbitrap mass spectrometer (GC-HRMS). A targeted analysis was performed to quantify the four certified POPs: hexachlorobenzene (HCBz) and hexachlorobutadiene (HCBu) in ERM®-CE100 and pentachlorobenzene (PeCB) and α, β, γ, and δ-hexachlorocyclohexane (HCH) in ERM®-CE103. Quantitative estimations obtained with ROIMCR method were compared with those obtained using the instrument vendor's Xcalibur software. Two tailed t-tests were performed and good agreement was observed between the two approaches and with the certified values. A non-targeted analysis approach was then performed to characterize other unknown POPs present in the samples. Data processed with the ROIMCR method in the non-targeted acquisition mode was complemented with the MSident chemical identification procedure, which allowed the annotation of several polycyclic aromatic hydrocarbons (PAHs), organochlorine pesticides (OCPs), phthalates, and polychlorinated biphenyls (PCBs). The presence of some of these compounds was confirmed with the analysis of validation standard mixture samples containing 43 POPs. The ROIMCR methodology herein proposed allows, in a first instance, the quantitative analysis of multiple unknown contaminants present in the analyzed fish-based certified samples by using GC-HRMS data and also, combined with the MSident program, enables a qualitative analysis which could provide a comprehensive assessment of POP pollution patterns in fish or other environmental samples.},
}

Animals
*Gas Chromatography-Mass Spectrometry/standards/methods
*Fishes
*Persistent Organic Pollutants
Reference Standards

@article {pmid41353609,
year = {2026},
author = {Van Beckhoven, D and Serrien, B and Demeester, R and Van Praet, J and Messiaen, P and Darcis, G and Henrard, S and De Munter, P and Libois, A and Deblonde, J},
title = {Reply to Satapathy et al.'s comment on "Dual cross-sectional and longitudinal perspective on the continuum of HIV care to disentangle natural epidemic evolution from real progress, Belgium 2014-2022".},
journal = {HIV medicine},
volume = {27},
number = {2},
pages = {328-331},
doi = {10.1111/hiv.70163},
pmid = {41353609},
issn = {1468-1293},
}

@article {pmid41354105,
year = {2026},
author = {Mendes Araújo, L and Chianca, T and Persaud, C and Hartung, P and Soares, Y and Almirón, G and João, R},
title = {Respiratory strength training for patients with amyotrophic lateral sclerosis: A meta-analysis of randomized controlled trials.},
journal = {Respiratory medicine},
volume = {251},
number = {},
pages = {108560},
doi = {10.1016/j.rmed.2025.108560},
pmid = {41354105},
issn = {1532-3064},
mesh = {Humans ; *Amyotrophic Lateral Sclerosis/physiopathology/rehabilitation/therapy ; Randomized Controlled Trials as Topic ; *Breathing Exercises/methods ; Male ; Middle Aged ; Respiratory Muscles/physiopathology ; *Resistance Training/methods ; Female ; Treatment Outcome ; Aged ; Maximal Respiratory Pressures ; },
abstract = {INTRODUCTION: Respiratory strength training (RST) has been considered as a possible add-on treatment for amyotrophic lateral sclerosis (ALS). However, the benefits of RST are still controversial. We performed a meta-analysis of randomized controlled trials (RCTs) on the efficacy of RST in patients with ALS.

METHODS: PubMed, Embase and Cochrane Central were searched for RCTs comparing the use of RST with sham therapy or minimal device load in patients with ALS. The main outcomes were maximal expiratory pressure (MEP), maximal inspiratory pressure (MIP) and the ALS functioning rating scale (ALSFRS-R) score. Statistical analysis was performed using R software and heterogeneity was assessed with I[2] statistics.

RESULTS: Four RCTs were included with a total of 138 patients. RST was used to treat 69 (50 %) patients. The mean age was 60.2 ± 10.4 years, with 82 (62.3 %) male patients. Follow-up ranged from 2 to 8 months. Subgroup analysis of expiratory muscle training protocols showed a statistically significant improvement in MEP (MD 20.22 cmH2O; 95 % CI 2.66-37.77; p = 0.04). In overall analyses, there was no difference between groups regarding MEP (MD 9.40 cmH2O; 95 % CI -11.57-30.37; p = 0.25), MIP (MD 3.26 cmH2O; 95 % CI -9.23-15.75; p = 0.38), FVC (MD 4.05 %predicted; 95 % CI -0.91-9.01; p = 0.08) and ALSFRS-R score (MD 0.01 points; 95 % CI -0.29-0.32; p = 0.85).

CONCLUSION: In this meta-analysis of RCTs including patients with ALS, expiratory muscle training was associated with increased MEP compared with sham or minimal load. However, no statistically significant associations were found for overall RST in MIP, FVC, MEP, and ALSFRS-R.},
}

Humans
*Amyotrophic Lateral Sclerosis/physiopathology/rehabilitation/therapy
Randomized Controlled Trials as Topic
*Breathing Exercises/methods
Male
Middle Aged
Respiratory Muscles/physiopathology
*Resistance Training/methods
Female
Treatment Outcome
Aged
Maximal Respiratory Pressures

@article {pmid41354564,
year = {2025},
author = {Mouhi, S and Pio, T and Andersen, J},
title = {Revisiting oligodendrocytes in amyotrophic lateral sclerosis using human multicellular stem cell models.},
journal = {Trends in cell biology},
volume = {},
number = {},
pages = {},
pmid = {41354564},
issn = {1879-3088},
support = {F31 NS135955/NS/NINDS NIH HHS/United States ; },
abstract = {Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive motor neuron degeneration, muscle wasting, and eventual paralysis. The clinical and genetic complexity along with rapid disease progression has hindered efforts to model the disease and develop effective treatments. Rodent models and human tissue studies point to dysfunction in oligodendrocyte lineage cells early in disease, although the underlying mechanisms remain unclear. Advances in stem cell research have introduced novel platforms to investigate cells in the oligodendrocyte lineage and their interactions with neurons and other glial cells in complex human genetic backgrounds. This Review summarizes the literature implicating oligodendrocyte lineage cells in ALS and discusses both the potential and limitations of in vitro-derived cultures to shed light on their vulnerabilities and cellular interactions.},
}

@article {pmid41354852,
year = {2025},
author = {Oraha, J and Wagner, R and Bergh, S and Lee, NJ and Kirik, D and Petersén, Å},
title = {Differential effects of overexpression of mutant huntingtin and TDP-43 in agouti-related protein neurons in the arcuate nucleus of the hypothalamus in mice.},
journal = {Acta neuropathologica communications},
volume = {13},
number = {1},
pages = {253},
pmid = {41354852},
issn = {2051-5960},
mesh = {Animals ; *DNA-Binding Proteins/genetics/metabolism ; *Neurons/metabolism/pathology ; *Agouti-Related Protein/metabolism/genetics ; Male ; *Arcuate Nucleus of Hypothalamus/metabolism/pathology ; Female ; Mice ; Mice, Transgenic ; *Nerve Tissue Proteins/genetics/metabolism ; Huntingtin Protein ; Humans ; Mutation/genetics ; *Nuclear Proteins/genetics/metabolism ; Mice, Inbred C57BL ; },
abstract = {The spectrum of frontotemporal dementia/amyotrophic lateral sclerosis (FTD/ALS) and Huntington disease (HD) are fatal neurodegenerative disorders with no major disease-modifying therapies. Recent work has shown that the hallmark pathological proteins TAR DNA binding protein of 43 kDa (TDP-43) in FTD/ALS and mutant huntingtin (mHTT) in HD may be interlinked. Furthermore, these disorders share early features of altered metabolism and psychiatric symptoms that have been suggested to arise from pathology in the hypothalamus, an important brain region involved in the regulation of metabolism and emotions. Agouti-related protein (AgRP)-expressing neurons localised exclusively to the arcuate nucleus (ARC) of the hypothalamus are key modulators of body weight regulation and food seeking behaviour, and they have recently been implicated in anxiety- and anhedonic-like processes. The aim of this study was to investigate the effects of overexpression of TDP-43 or mHTT in AgRP-expressing neurons on metabolic, behavioral and neuropathological features in mice. Flex-switch adeno associated viral vectors expressing human wild-type TDP-43, mHTT or green fluorescent protein to serve as a control, were injected into male and female AgRP-Cre mice to target the ARC using stereotactic surgery. We demonstrate targeted overexpression of transgenes including formation of mHTT inclusions in the ARC of the hypothalamus. Overexpression of mHTT led to a significant reduction in AgRP fibres in the hypothalamus 21 weeks post-injection, as well as higher food consumption in female mice. Overexpression of TDP-43 did not lead to the development of any metabolic or behavioral phenotypes in the mice. Our data suggest that AgRP neurons in the ARC are protected from the toxic effects resulting from overexpression of TDP-43 whereas they display some sensitivity to mHTT overexpression resulting in mHTT inclusion formation, reduction in AgRP fibers and sex-specific effects on food consumption. Taken together, other hypothalamic neuronal populations may be more important for the development of non-motor features resulting from overexpression of TDP-43 and mHTT in the hypothalamus.},
}

Animals
*DNA-Binding Proteins/genetics/metabolism
*Neurons/metabolism/pathology
*Agouti-Related Protein/metabolism/genetics
Male
*Arcuate Nucleus of Hypothalamus/metabolism/pathology
Female
Mice
Mice, Transgenic
*Nerve Tissue Proteins/genetics/metabolism
Huntingtin Protein
Humans
Mutation/genetics
*Nuclear Proteins/genetics/metabolism
Mice, Inbred C57BL

@article {pmid41354869,
year = {2025},
author = {Tahedl, M and Kleinerova, J and McKenna, MC and Siah, WF and Hardiman, O and Hengeveld, JC and Doherty, MA and McLaughlin, RL and Tan, EL and Hutchinson, S and Bede, P},
title = {Putative mitochondrial components of frontotemporal lobar degeneration: topological correlations between mitochondrial density and atrophy in FTLD/FTD phenotypes.},
journal = {Journal of neurology},
volume = {273},
number = {1},
pages = {11},
pmid = {41354869},
issn = {1432-1459},
support = {(HRB EIA-2017-019/HRBI_/Health Research Board/Ireland ; JPND-Cofund-2-2019-1/HRBI_/Health Research Board/Ireland ; SFI SP20/SP/8953/SFI_/Science Foundation Ireland/Ireland ; },
mesh = {Humans ; Male ; Female ; Atrophy/pathology ; *Frontotemporal Lobar Degeneration/pathology/diagnostic imaging/metabolism/genetics ; Middle Aged ; Aged ; *Mitochondria/pathology/metabolism ; *Frontotemporal Dementia/pathology/diagnostic imaging ; Phenotype ; Magnetic Resonance Imaging ; *Brain/pathology/diagnostic imaging ; Prospective Studies ; },
abstract = {BACKGROUND: Frontotemporal lobar degeneration encompasses a spectrum of clinically, radiologically, and molecularly heterogeneous conditions. Clinical phenotypes are defined based on predominant neuropsychological manifestations and the selective involvement of specific brain regions determines the core symptoms, disability profiles, and care needs. While the unique anatomical patterns of cortical and subcortical degeneration along the FTLD/FTD spectrum are well recognised, the molecular basis of this selective vulnerability remains unclear.

METHODS: A large prospective neuroimaging study has been undertaken to explore topological associations between phenotype-specific atrophy patterns and physiological mitochondrial density along the FTLD/FTD spectrum. Patients with behavioural variant FTD (bvFTD), nonfluent variant primary progressive aphasia (nfvPPA), semantic variant primary progressive aphasia (svPPA), C9orf72-positive ALS-FTD, C9orf72-negative ALS-FTD, and a cohort of healthy controls (HC) were included. FTD phenotypes were first contrasted to healthy controls and the resulting voxelwise maps were correlated to physiological mitochondrial density maps.

RESULTS: We have identified voxelwise associations between atrophic change and physiological mitochondrial density. The resulting correlation coefficients over the entire GM mask revealed weak topological associations with r = 0.217 in C9NEG ALS-FTD, r = 0.251 in C9POS ALS-FTD, r = 0.213 in bvFTD, r = 0.182 in nfvPPA, and r = 0.292 in svPPA at p FWE < 0.001. Our region-of-interest analyses revealed moderate-to-strong regional associations between mitochondrial density and focal degenerative change with r values above 0.65 in multiple brain regions in all five FTD subgroups. Brain regions exhibiting the most significant associations between volume loss and mitochondrial density in each FTD subgroup are the very regions that define the core clinical manifestations of the given phenotype.

DISCUSSION: Cortical and subcortical brain regions with high physiological mitochondrial density are particularly vulnerable to neurodegenerative change in FTD. While these anatomical associations do not indicate direct causation, mitochondrial metabolism may represent an important component in the cascade of focal degeneration.},
}

Humans
Male
Female
Atrophy/pathology
*Frontotemporal Lobar Degeneration/pathology/diagnostic imaging/metabolism/genetics
Middle Aged
Aged
*Mitochondria/pathology/metabolism
*Frontotemporal Dementia/pathology/diagnostic imaging
Phenotype
Magnetic Resonance Imaging
*Brain/pathology/diagnostic imaging
Prospective Studies

@article {pmid41355168,
year = {2025},
author = {Cline, LL and Biggs, R and Butler, JS and Nichols, C},
title = {A Systems-Approach to Addressing the US Rural Veterinarian Shortage Through Collaborative Problem-Solving Training and Education.},
journal = {New directions for student leadership},
volume = {2025},
number = {188},
pages = {97-105},
doi = {10.1002/yd.70028},
pmid = {41355168},
issn = {2373-3357},
mesh = {Humans ; *Problem Solving ; *Education, Veterinary/organization & administration ; *Leadership ; *Veterinarians/supply & distribution ; *Rural Population ; United States ; Oklahoma ; Cooperative Behavior ; Workforce ; },
abstract = {The shortage of rural veterinarians in the United States poses significant challenges to food security, public health, and the agricultural economy. This article explores two systems-based training strategies to address this issue through two case studies: the Integrated Beef Cattle Program (IBCP) in the College of Veterinary Medicine (CVM) at Oklahoma State University (OSU) and the development of adaptive leadership and collaborative problem-solving capacity among rural veterinarians at Pat Dye Clinics. Grounded in Heifetz et al.'s (2009) adaptive leadership framework and Kirton's (2011) Adaption-Innovation Theory (A-I theory), these initiatives demonstrate how leadership development and cognitive diversity can enhance recruitment, retention, and resilience in rural veterinary practice. Findings suggest that integrating leadership learning in veterinary education and professional development can serve as a critical leverage point for systemic change.},
}

Humans
*Problem Solving
*Education, Veterinary/organization & administration
*Leadership
*Veterinarians/supply & distribution
*Rural Population
United States
Oklahoma
Cooperative Behavior
Workforce

@article {pmid41355171,
year = {2026},
author = {Lağap, AC and Harma, M},
title = {Does Your Love Lift Me Higher? A Direct Replication of the Energising Role of Secure Relationships.},
journal = {International journal of psychology : Journal international de psychologie},
volume = {61},
number = {1},
pages = {e70144},
doi = {10.1002/ijop.70144},
pmid = {41355171},
issn = {1464-066X},
mesh = {Humans ; Female ; Male ; *Motivation ; *Love ; Adult ; *Object Attachment ; Young Adult ; *Interpersonal Relations ; Adolescent ; },
abstract = {Previous work has revealed that priming people with significant others increases feelings of security and energy, and in turn, boosts exploration motivations. In this preregistered study, we directly replicated Luke et al.'s (2012) Study 2 (N = 281). We found similar results as the replicated study regarding increased security feelings and exploration motivations on the self-report measures after the priming. However, we did not find any support for the increased energy feelings after the attachment security priming. In addition, contrary to Luke et al.'s (2012) results, energy feelings did not mediate the relationship between security priming and exploration motivations. A discussion of null findings, along with the limitations of self-reports and potential misinterpretation of the mediational analyses, follows. We also discuss possible future implications of the current findings.},
}

Humans
Female
Male
*Motivation
*Love
Adult
*Object Attachment
Young Adult
*Interpersonal Relations
Adolescent

@article {pmid41355735,
year = {2025},
author = {Pal, P and Carrer, M and Weiss, L and Jaime, OG and Cheng, C and Shmara, A and Boock, V and Bosch, D and Youssef, M and Fazeli, Y and Afetian, M and Grossman, TR and Hicks, MR and Jafar-Nejad, P and Kimonis, V},
title = {Antisense oligonucleotides targeting valosin-containing protein ameliorate muscle pathology and molecular defects in cell and mouse models of multisystem proteinopathy.},
journal = {Clinical and translational medicine},
volume = {15},
number = {12},
pages = {e70530},
pmid = {41355735},
issn = {2001-1326},
support = {1297770//Muscular Dystrophy Association/ ; //Cure VCP Disease Inc. Ionis Pharmaceuticals, Inc./ ; },
mesh = {Animals ; *Valosin Containing Protein/genetics/metabolism/antagonists & inhibitors ; Mice ; *Oligonucleotides, Antisense/pharmacology/therapeutic use ; Disease Models, Animal ; Humans ; Muscle, Skeletal/pathology ; Muscular Dystrophies, Limb-Girdle/genetics ; Frontotemporal Dementia/genetics ; Myositis, Inclusion Body ; Osteitis Deformans/genetics ; },
abstract = {BACKGROUND: Valosin-containing protein (VCP) related disease, also known as multisystem proteinopathy 1 (MSP1), is an autosomal dominant disease caused by gain-of-function pathogenic variants of the VCP gene. The disease presents with variable combinations of inclusion body myopathy, early-onset Paget's disease of bone, frontotemporal dementia and may also overlap with familial amyotrophic lateral sclerosis. There is currently no treatment for this progressive disease associated with early demise resulting from proximal limb girdle and respiratory muscle weakness. We hypothesise that regulating VCP hyperactivity to normal levels can reduce the disease pathology.

MAIN TOPICS COVERED: In this study, we assessed the effect of antisense oligonucleotides (ASOs) specifically targeting the human VCP gene in the patient (R155H) iPSC-derived skeletal muscle progenitor cells (SMPCs). ASOs were well tolerated up to a concentration of 5 µM and significantly reduced VCP protein expression in the SMPCs by 48% (95% CI [39-56]). We also treated the transgenic mouse model of VCP disease with the overexpressed humanised VCP severe A232E pathogenic gene variant (VCP A232E mice) with weekly subcutaneous ASO injections starting from 6 months of age for 3 months. In the skeletal muscle of transgenic mice, ASOs resulted in 30% (95% CI [27-32]) knockdown of VCP protein compared with control ASO. The ASO-mediated reduction of VCP expression in muscle tissue was associated with improvement in autophagy flux and reduction in TAR DNA binding protein 43 (TDP-43) expression, hallmarks of VCP related MSP1. In addition, ASO-treated VCP A232E mice showed improvements in functional tests of muscle strength, such as rotarod and inverted screen test compared with mice treated with control ASO.

CONCLUSIONS: These results suggest that targeting VCP could be beneficial in preventing the progression of the VCP myopathy and hold promise for the treatment of patients with VCP related MSP1.

KEY POINTS: VCP multisystem proteinopathy 1 is caused by gain-of-function pathogenic variants of the VCP gene. VCP targeting ASOs were well tolerated and significantly reduced VCP, TAR DNA binding protein 43 (TDP 43), and autophagy protein expression in the (R155H) iPSC-derived skeletal muscle progenitor cells (SMPCs). The ASOs reduced VCP, TDP-43, and autophagy flux expression, and improved functional tests of muscle strength in the humanized VCP A232E mice.},
}

Animals
*Valosin Containing Protein/genetics/metabolism/antagonists & inhibitors
Mice
*Oligonucleotides, Antisense/pharmacology/therapeutic use
Disease Models, Animal
Humans
Muscle, Skeletal/pathology
Muscular Dystrophies, Limb-Girdle/genetics
Frontotemporal Dementia/genetics
Myositis, Inclusion Body
Osteitis Deformans/genetics

@article {pmid41356579,
year = {2025},
author = {Seyam, MK and Shaik, RA and Miraj, M and Alzahrani, NS and Shaik, AR and Ajmera, P and Kalra, S and Miraj, SA and Shawky, GM and Nurani, KM and A, P},
title = {Effect of mobile phone applications on medication adherence among patients with coronary artery diseases: A scoping review.},
journal = {World journal of cardiology},
volume = {17},
number = {11},
pages = {114140},
pmid = {41356579},
issn = {1949-8462},
abstract = {Patients with cardiovascular disease rely on medication to achieve favorable long-term clinical results. Poor adherence has been linked to a relative increase in mortality of 50%-80% as well as higher health care costs. This scoping review thus aimed to explore the evidence of the effects of mobile health care apps on medication adherence in patients with cardiovascular diseases. A comprehensive data search and extraction was done in line with the updated Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews checklist. A total of 10 studies were included for the review. The mean pooled improvement in adherence was found to be 18% and the most effective tool was the digital therapeutics app discussed in Li et al's study. Smartphones and apps enhance coronary artery disease management by promoting medication compliance. Challenges include data security and smartphone usage among the elderly. Tailored apps or voice assistants offer potential solutions.},
}

@article {pmid41356587,
year = {2025},
author = {Liu, HR and Weng, JL},
title = {Interpreting fractional flow reserve-guided percutaneous coronary intervention vs coronary artery bypass grafting outcomes.},
journal = {World journal of cardiology},
volume = {17},
number = {11},
pages = {113225},
pmid = {41356587},
issn = {1949-8462},
abstract = {Kataveni et al's meta-analysis offers an important contemporary synthesis of randomized evidence comparing fractional flow reserve-guided percutaneous coronary intervention and coronary artery bypass grafting (CABG) in multivessel coronary artery disease (CAD). The pooled analysis found no significant difference in all-cause mortality or stroke, yet CABG was superior in reducing myocardial infarction, major adverse cardiac events, and repeat revascularization. These results confirm CABG's durability even in the era of physiological lesion assessment and second-generation drug-eluting stents. From a traditional Chinese medicine (TCM) perspective, multivessel CAD corresponds to syndromes such as "heart vessel obstruction" and "Qi and blood stagnation", in which local blockage is compounded by systemic imbalance. While revascularization addresses the structural impediment to blood flow, TCM approaches, including herbal medicine, acupuncture, and lifestyle therapy, aim to improve microcirculation, reduce inflammation, and support recovery, potentially mitigating recurrent ischemic events. This commentary argues that future research should integrate optimal revascularization strategies with rigorously evaluated TCM interventions to address both the anatomical and systemic dimensions of CAD and improve long-term patient outcomes.},
}

@article {pmid41359166,
year = {2025},
author = {Gondim, FAA and Fernandes, JMA and Dutra Junior, AM and Thomas, FP},
title = {Four families with slowly progressive ALS due to p.Val120Leu SOD1 variant in Northeast Brazil.},
journal = {Amyotrophic lateral sclerosis & frontotemporal degeneration},
volume = {},
number = {},
pages = {1-5},
doi = {10.1080/21678421.2025.2597943},
pmid = {41359166},
issn = {2167-9223},
abstract = {Objective: SOD1 mutations are the second most prevalent variants in amyotrophic lateral sclerosis (ALS). Epidemiological data about SOD1 mutations are scarce in Brazil. Here, we report the clinical and genetic findings of four Brazilian families with p.Val120Leu SOD1 variant. Methods: This study is part of an epidemiological study of the prevalence of ALS conducted in the State of Ceará, Brazil. We reviewed the medical records of families with p.Val120Leu (c.358G > C, exon 5) SOD1 variant seen at the Walter Cantídio University Hospital, Federal University of Ceará, Brazil. Results: We identified 15 patients from 4 families with p.Val120Leu SOD1 variant among 251 ALS patients. Of these, six were personally examined and had ALS confirmed and five had confirmatory genetic testing (four homozygous and one heterozygous). C9orf72 testing was normal in the heterozygous patient. In two families, three older heterozygous patients (genetically tested) had no signs or symptoms of ALS. The mean age of symptom onset was 46.7 ± 13.4 years. Features of ALS in the four families were very similar, with prolonged disease duration and upper and lower motor neuron involvement, fulfilling the Revised El Escorial, Awaji, and Gold Coast diagnostic criteria. All examined living patients had limb onset and a few bulbar symptoms. Conclusion: p.Val120Leu SOD1 variant leads to slowly progressive ALS with incomplete penetrance. Our findings are similar to a previous report of ALS due to p.Asp90Ala SOD1 variant.},
}

@article {pmid41359202,
year = {2025},
author = {Guerra-Hernández, J and Mauro-Gutiérrez, F and Rodríguez-Puerta, F and Pascual, A},
title = {Scaling and sampling dependencies of forest canopy height mapping towards jurisdictional biomass reporting using airborne LiDAR and small-area estimation.},
journal = {Carbon balance and management},
volume = {21},
number = {1},
pages = {12},
pmid = {41359202},
issn = {1750-0680},
support = {2023.15225.TENURE.008//Fundação para a Ciência e a Tecnologia/ ; PID2022-140104OA-I00//Spanish Ministry of Science and Innovation/ ; },
abstract = {Consolidated airborne laser scanning (ALS) programs, satellite imagery and spaceborne structural measurements have enabled major advances in canopy height mapping that translate towards the forest carbon biomass arena. However, we must carefully evaluate the cost of using fine-grained canopy height products to predict biomass under calibration models scoped at the scale of inventory plots. In this study, we estimated biomass using field plots and ALS metrics before predicting biomass over a jurisdiction of ~ 15,500 km[2] in Spain using 10 m, 25 m, 44 m, and 100 m as prediction scales. We altered the scale of ALS-based biomass predictors in 10 sub-jurisdictions intensively surveyed by the Spanish National Forest Inventory (NFI) before estimating mean and total biomass using three options: (i) traditional NFI design-based (DB) estimation, (ii) a model-based (MB) approach using scale-varying canopy height metrics from ALS and NFI plots, and (iii) an small-area estimation (SAE) implemntation designed for sub-jurisdictional domains. Higher uncertainties - relative standard errors (SE) - were found for DB, particularly at sub-jurisdictional and stratum levels. We observed a consistent increase in uncertainty for MB estimation from the finest 10 m scale up to 100 m. In MB estimation, the maximum relative bias reached 11% for 10-m predictions compared to the baseline estimate at the NFI sampling native resolution. The bias associated with the prediction scale ranged from + 5% (25 m) to -8% (100 m). The mean biomass estimates for SAE generally ranged between DB and MB but at lower uncertainty to the former, especially as the NFI sampling becomes scarcer and not enough for solid inference of biomass mean. The SEA statistics helped to disentangle biomass comparisons between ALS-based inference and the traditional NFI estimation that do not incorporate remote sensing data.},
}

@article {pmid41359433,
year = {2025},
author = {Zulhairy-Liong, NA and Edgar, S and Ellis, M and Zhu, D and Lai, K and Capelle, DP and Sabirin, S and Pek, EW and Nair, P and Ang, CM and Kennerson, ML and Shahrizaila, N and Ahmad-Annuar, A},
title = {Novel and rare variants in amyotrophic lateral sclerosis genes identified in Malaysian patients.},
journal = {Amyotrophic lateral sclerosis & frontotemporal degeneration},
volume = {},
number = {},
pages = {1-10},
doi = {10.1080/21678421.2025.2582832},
pmid = {41359433},
issn = {2167-9223},
abstract = {There is limited information on the genetic architecture of amyotrophic lateral sclerosis (ALS) in Southeast Asian populations. To address this knowledge gap, we performed 1) SOD1 (exon 1-4), FUS (exon 13-15), TARDBP (exon 6) and ATXN2 repeat expansion screening in 201 multi-ethnic Malaysian (Malay, Chinese, Indian and others) ALS patients, 2) C9orf72 repeat expansion testing in 179 subset patients, and 3) a panel of 61 ALS-associated genes screening in 112 subset cases using either whole genome (n = 21) or exome (n = 91) sequencing datasets. Among the patients, the observed mutational frequencies in key ALS genes were: SOD1 3.0% (6/201), C9orf72 2.2% (4/179), ATXN2 2.0% (4/201), FUS 1.5% (3/201), and TARDBP 1.5% (3/201). Of the 112 cases that underwent WGS/WES, 6.3% (7/112) comprised of pathogenic and likely pathogenic variants in FIG4 (p.Lys657Serfs*2), FUS (p.Arg485Profs*32), TARDBP (p.Ile383del), NEK1 (p.Ile633Asnfs*28), GRN (c.599-1G > C), CYP27A1 (p.Met1Thr) and SPAST (p.Glu449Gly). Additionally, 42.9% (48/112) had at least one variant of uncertain significance (VUS) in 34 genes. Notably, in the 24 genes classified as 'definitive' by the ClinGen ALS Spectrum Disorders Gene Curation Expert Panel, five patients (4.5%, 5/112) harbored more than one likely pathogenic variant and/or VUS. However, burden analysis revealed no significant differences in clinical characteristics between patients with varying numbers of variants. Our findings highlight the utility of next-generation sequencing in elucidating the genetic basis of ALS in Malaysian and Southeast Asian ethnic groups, including the identification of several novel variants of clinical interest as well as increasing diagnostic yield up to 47.7%.},
}

@article {pmid41359530,
year = {2025},
author = {Rees, L and Lam, CF and Du, QS and Yu, A and Wong, MN and Xie, H},
title = {Exploring the duality of voice habit: Testing and extending theory and measurement.},
journal = {The Journal of applied psychology},
volume = {},
number = {},
pages = {},
doi = {10.1037/apl0001326},
pmid = {41359530},
issn = {1939-1854},
support = {//National Natural Science Foundation of China/ ; //Hong Kong General Research Fund/ ; },
abstract = {Scholars increasingly recognize the existence of voice habit, wherein employees speak up automatically without considering relevant situational factors, being able to control their impulse to voice, and exerting effort in deciding whether to voice. However, a lack of theory testing and an absence of a psychometrically valid measure have called into question its theoretical usefulness as well as its construct validity. Moreover, contrary to Lam et al.'s (2018) theorizing on the interpersonal costs and intrapersonal benefits of voice habit, research on the reticence bias suggests the opposite: Habitual voicers may gain interpersonal benefits by experiencing higher supervisor liking, but they may also suffer intrapersonal costs by experiencing voice regret. Integrating these divergent insights with theorizing on voice habit, we predict that voice habit may elicit supervisor liking when supervisors perceive habitual voicers as having higher prosocial motives or behavioral integrity, even though habitual voicers may experience regret in work units with a weaker voice climate. Results from a multiwave, multisource field study with 435 employees and 135 supervisors using a 12-item validated scale of voice habit support our hypotheses. Our work provides a direct test and extension of the recently proposed theorizing on voice habit and introduces a psychometrically valid measure for future research use. Our findings also empirically support the dual nature of voice habit, highlighting both its potential functional interpersonal outcomes in relation to supervisors and its potential dysfunctional intrapersonal outcomes for habitual voicers. (PsycInfo Database Record (c) 2025 APA, all rights reserved).},
}

@article {pmid41359535,
year = {2026},
author = {Bollen, C and van Grunsven, J},
title = {In defense of the double empathy problem hypothesis: An urgently needed alternative to fallacies and injustices in mainstream autism research.},
journal = {Psychological review},
volume = {133},
number = {2},
pages = {507-514},
doi = {10.1037/rev0000605},
pmid = {41359535},
issn = {1939-1471},
support = {//Netherlands Organisation for Scientific Research/ ; },
mesh = {Humans ; *Empathy ; *Autistic Disorder/psychology ; *Autism Spectrum Disorder/psychology ; *Psychological Theory ; },
abstract = {In their theoretical note, "The Double Empathy Problem: A Derivation Chain Analysis and Cautionary Note," Livingston et al. (2024) took a critical look at the double empathy problem hypothesis (DEPH). While they acknowledge that the DEPH offers promising insights, and while their critical note seems, at times, to be written with an eye to furthering and expanding DEPH, the main point they ultimately drive home is that DEPH has a "precarious theoretical and evidence base" and that, given this (allegedly) shaky foundation, applying DEPH "into real-world applications may have unintended and potentially harmful consequences for autistic people and those with similar conditions" (Livingston et al., 2024, p. 10). In this theoretical note, we take a critical look at Livingston et al.'s critique of DEPH, arguing that their warning note is problematic both from an ethical and philosophy of science point of view. (PsycInfo Database Record (c) 2026 APA, all rights reserved).},
}

Humans
*Empathy
*Autistic Disorder/psychology
*Autism Spectrum Disorder/psychology
*Psychological Theory